Nos publications

Nos Articles

Pôle d'Unité "RADIOBIOLOGIE FONDAMENTALE"

2020

Ferlazzo M, Berthel E, Granzotto A, Devic C, Sonzogni L, Bachelet JT, Pereira S, Bourguignon M, Sarasin A, Mezzina M, Foray N. Some mutations in the xeroderma pigmentosum D gene may lead to moderate but significant radiosensitivity associated with a delayed radiation-induced ATM nuclear localization. Int J Radiat Biol. 2020 Mar;96(3):394-410.

Farhat D, Ghayad SE, Icard P, Le Romancer M, Hussein N, Lincet H.Lipoic acid-induced oxidative stress abrogates IGF-1R maturation by inhibiting the CREB/furin axis in breast cancer cell lines. Oncogene. 2020 Feb 14

Farhat D, Léon S, Ghayad SE, Gadot N, Icard P, Le Romancer M, Hussein N, Lincet H.Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation. Br J Cancer. 2020 Mar;122(6):885-894.

Stallcup M and Poulard C. Gene-specific actions of transcriptional coregulators facilitate physiological plasticity: Evidence for a physiological coregulator code. Trends in Biochemical sciences. In press, 2020.

Montaudié H, Viotti J, Combemale P, Dutriaux C, Dupin N, Robert C, Mortier L, Kaphan R, Duval-Modeste AB, Dalle S, De Quatrebarbes J, Stefan A, Brunet-Possenti F, Kogay M, Picard-Gauci A, Poissonnet G, Peyrade F. Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study. Oncotarget. 2020 Jan 28;11(4):378-385. doi: 10.18632/oncotarget.27434. eCollection 2020 Jan 28.

Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P; NF France Network. Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphanet J Rare Dis. 2020 Feb 3;15(1):37. doi: 10.1186/s13023-020-1310-3.

Melero I, Shekarian T, Gato M, Aznar A , Caux C, Marabelle A and Valsesia-Wittmann S. Repurposing infectious disease vaccines for intratumoral immunotherapy. J Immunother Cancer. 2020 Feb;8(1). pii: e000443. doi: 10.1136/jitc-2019-000443.

2019

Dummer R, Guminksi A, Gutzmer R, Lear JT, Lewis KD, Chang ALS, Combemale P, Dirix L, Kaatz M, Kudchadkar R, Loquai C, Plummer R, Schulze HJ, Stratigos AJ, Trefzer U, Squittieri N, Migden MR. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18552. [Epub ahead of print]

Shekarian T, Sivado E, Jallas AC, Depil S, Kielbassa J, Janoueix-Lerosey I, Hutter G, Goutagny N, Bergeron C, Viari A, Caux C*, Marabelle A* and Valsesia-Wittmann S*. Repurposing Rotavirus vaccines as oncolytic virus can overcome resistance to Immune Checkpoint targeted Therapy. Science Translational Medicine aat5025. 2019 Oct 23; 11 (515)

Poulard C, Jacquemetton J, Pham TH, Le Romancer M. Using proximity ligation assay to detect protein arginine methylation.Methods. 2019 Sep 6. pii: S1046-2023(19)30191-4.

Poulard C, Jacquemetton J, Trédan O, Cohen PA, Vendrell J, Ghayad SE, Treilleux I, Marangoni E, Le Romancer M. Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer. Int J Mol Sci. 2019 Jun 5;20(11).

Maillet D, Allioli N, Peron J, Plesa A, Decaussin-Petrucci M, Tartas S, Ruffion A, Crouzet S, Rimokh R, Gillet PG, Freyer G, Vlaeminck-Guillem V.Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients.Eur Urol Oncol. 2019 Oct 29.

Redmond AM, Omarjee S, Chernukhin I, Le Romancer M, Carroll JS. Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation. PLoS One. 2019 Nov 20;14(11):e0225180.

Maalouf M, Granzotto A, Devic C, Bodgi L, Ferlazzo M, Peaucelle C, Bajard M, Giraud JY, Balosso J, Hérault J, Biston MC, Malet C, Foray N. Influence of Linear Energy Transfer on the Nucleo-shuttling of the ATM Protein: A Novel Biological Interpretation Relevant for Particles and Radiation. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):709-718.

Lattouf H, Poulard C, Le Romancer M. PRMT5 prognostic value in cancer.Oncotarget. 2019 May 7;10(34):3151-3153.

Poulard C, Kim HN*, Fang M*, Kruth K, Gagnieux C, Gerke DS, Bhojwani D, Kim YM, Kampmann M, Stallcup MR, Pufall MA. Functional genomic analysis of relapse in B-cell acute lymphoblastic leukemia identifies AURKB as a target to enhance glucocorticoid sensitivity. PNAS. 2019 Feb 19;116(8):3052-3061.

Choucair A, Pham TH, Omarjee S, Jacquemetton J, Kassem L, Trédan O, Rambaud J, Marangoni E, Corbo L, Treilleux I, Le Romancer M. The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer. Oncogene. 2019 May;38(21):4015-4027.

Lattouf H, Kassem L, Jacquemetton J, Choucair A, Poulard C, Trédan O, Corbo L, Diab-Assaf M, Hussein N, Treilleux I, Le Romancer M. LKB1 regulates PRMT5 activity in breast cancer. Int J Cancer. 2019 Feb 1;144(3):595-606.

2018

Vogin G, Bastogne T, Bodgi L, Gillet-Daubin J, Canet A, Pereira S, Foray N. The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):690-693..

Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo ML, Devic C, Granzotto A, Deneuve S, Vogin G, Foray N. Fast and Binary Assay for Predicting Radiosensitivity Based on the Theory of ATM Nucleo-Shuttling: Development, Validation, and Performance. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):353-360.

Ferlazzo ML, Bach-Tobdji MKE, Djerad A, Sonzogni L, Devic C, Granzotto A, Bodgi L, Bachelet JT, Djefal-Kerrar A, Hennequin C, Foray N. Radiobiological Characterization of Tuberous Sclerosis: a Delay in the Nucleo-Shuttling of ATM May Be Responsible for Radiosensitivity. Mol Neurobiol. 2018 Jun;55(6):4973-4983

Sooyeon Lee, Peng Liu, Romain Teinturier, Miriam Tschaffon, Jeanette Knoll, Alpaslan Tasdogan, Rainer Wittig, Lucien Frappart, Philippe Bertolino, Chang Zhang, Jan Tuckermann. Deletion of Menin in craniofacial osteogenic cells in mice elicits development of mandibular ossifying fibroma. Oncogene, 37(5):616-626, 2018.

Manoharan J, Fendrich V, Di Fazio P, Bollmann C, Roth S, Joos B, Mintziras I, Albers M, Ramaswamy A, Bertolino P, Zhang CX, Slater EP, Bartsch DK, Lopez-Lopez C. Chemoprevention with enalapril and aspirin in Men1(+/T) knockout mouse model. Neuroendocrinology. 107(3):257-266, 2018.

 

Monteiro I, Vigano S, Faouzi M, Treilleux I, Michielin O, Ménétrier-Caux C, Caux C, Romero P, de Leval L. CD73 expression and clinical significance in human metastatic melanoma.Oncotarget. 2018 Jun 1;9(42):26659-26669.

 

Drouet Y, Treilleux I, Viari A, Léon S, Devouassoux-Shisheboran M, Voirin N, de la Fouchardière C, Manship B, Puisieux A, Lasset C, Moyret-Lalle C. Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer. Sci Rep. 2018 May 9;8(1):7386.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bull Cancer. 2018 Mar;105(3):299-314.

Nougarede A, Popgeorgiev N, Kassem L, Omarjee S, Borel S, Mikaelian I, Lopez J, Gadet R, Marcillat O, Treilleux I, Villoutreix BO, Rimokh R, Gillet G. Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.Cancer Res. 2018 Mar 15;78(6):1404-1417.

 

Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, Attignon V, Wang Q, Rogemond V, Lay S, Ray-Coquard I, Pfisterer J, Joly F, Du Bois A, Psimaras D, Bendriss-Vermare N, Caux C, Dubois B, Honnorat J, Desestret V. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 2018 Apr;135(4):569-579.

 

2017

Foy JP, Bazire L, Ortiz-Cuaran S, Deneuve S, Kielbassa J, Thomas E, Viari A, Puisieux A, Goudot P, Bertolus C, Foray N, Kirova Y, Verrelle P, Saintigny P. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes. BMC Med. 2017 Sep 1;15(1):165

Liu P, Lee S, Knoll J, Rauch A, Ostermay S, Luther J, Malkusch N, Lerner UH, Zaiss MM, Neven M, Wittig R, Rauner M, David JP, Bertolino P, Zhang CX, Tuckermann JP.Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis, Cell Death Diff 24 (4): 672-682. 2017.

Gherardi S, Ripoche D, Mikaelian I, Chanal M, Teinturier R, Goehrig D, Cordier-Bussat M, Zhang CX, Hennino A, Bertolino P. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification. Biochim Biophys Acta. 1860(4):427-437. 2017.

 

Chapat C, Chettab K, Simonet P, Wang P, De La Grange P, Le Romancer M, Corbo L Alternative splicing of CNOT7 diversifies CCR4-NOT functions. Nucleic Acids Res. 2017 Aug 21;45(14):8508-8523

 

Omarjee S, Jacquemetton J, Poulard C, Rochel N, Dejaegere A, Chebaro Y, Treilleux I, Marangoni E, Corbo L and Le Romancer M. The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer. Oncogene. 2017 May 4. 36(18):2503-2514.

Bellanger A, Donini CF, Vendrell JA, Lavaud J, Machuca-Gayet I, Ruel M, Vollaire J, Grisard E, Győrffy B, Bièche I, Peyruchaud O, Coll JL, Treilleux I, Maguer-Satta V, Josserand V, Cohen PA. The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone. J Pathol. 2017 May. 242(1):73-89.

Bonnavion R, Teinturier R, Gherardi S, Leteurtre E, Yu R, Cordier-Bussat M, Du R, Pattou F, Vantyghem MC, Bertolino P, Lu J, Zhang CX. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas. J Pathol. 2017 May. 242(1):90-101.

Clément F, Xu X, Donini CF, Clément A, Omarjee S, Delay E, Treilleux I, Fervers B, Le Romancer M, Cohen PA, Maguer-Satta V. Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling. Cell Death Differ. 2017 Jan;24(1):155-166.

 

Dantas-Barbosa C, Lesluyes T, Loarer FL, Chibon F, Treilleux I, Coindre JM, Meeus P, Brahmi M, Bally O, Ray-Coquard I, Sunyach MP, Cesne AL, Mir O, Bonvalot S, Toulmonde M, Italiano A, Saintigny P, Jean-Denis M, Ducimetiere F, Ranchere D, El Sayadi H, Alberti L, Blay JY. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma. Br J Cancer. 2017 Dec 5;117(12):1787-1797

 

Chuvin N, Vincent DF, Pommier RM, Alcaraz LB, Gout J, Caligaris C, Yacoub K, Cardot V, Roger E, Kaniewski B, Martel S, Cintas C, Goddard-Léon S, Colombe A, Valantin J, Gadot N, Servoz E, Morton J, Goddard I, Couvelard A, Rebours V, Guillermet J, Sansom OJ, Treilleux I, Valcourt U, Sentis S, Dubus P, Bartholin L. Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis. Cell Mol Gastroenterol Hepatol. 2017 May 31;4(2):263-282

 

Lin S, Negulescu A, Bulusu S, Gibert B, Delcros JG, Ducarouge B, Rama N, Gadot N, Treilleux I, Saintigny P, Meurette O, Mehlen P.

Non-canonical NOTCH3 signalling limits tumour angiogenesis. Nat Commun. 2017 Jul 18;8:16074.

 

Royet A, Broutier L, Coissieux MM, Malleval C, Gadot N, Maillet D, Gratadou-Hupon L, Bernet A, Nony P, Treilleux I, Honnorat J, Liebl D, Pelletier L, Berger F, Meyronet D, Castets M, Mehlen P. Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4. Oncotarget. 2017 Apr 4;8(14):23750-23759.

 

Chiannilkulchai N, Pautier P, Genestie C, Bats AS, Vacher-Lavenu MC, Devouassoux-Shisheboran M, Treilleux I, Floquet A, Croce S, Ferron G, Mery E, Pomel C, Penault-Llorca F, Lefeuvre-Plesse C, Henno S, Leblanc E, Lemaire AS, Averous G, Kurtz JE, Ray-Coquard I. Networking for ovarian rare tumors: a significant breakthrough improving disease management. Ann Oncol. 2017 Jun 1;28(6):1274-1279.

 

Bellanger A, Donini CF, Vendrell JA, Lavaud J, Machuca-Gayet I, Ruel M, Vollaire J, Grisard E, Győrffy B, Bièche I, Peyruchaud O, Coll JL, Treilleux I, Maguer-Satta V, Josserand V, Cohen PA. The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone. J Pathol. 2017 May;242(1):73-89.

 

Heudel PE, Fabbro M, Roemer-Becuwe C, Kaminsky MC, Arnaud A, Joly F, Roche-Forestier S, Meunier J, Foa C, You B, Priou F, Tazi Y, Floquet A, Selle F, Berton-Rigaud D, Lesoin A, Kalbacher E, Lortholary A, Favier L, Treilleux I, Ray-Coquard I. Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group. Br J Cancer. 2017 Jan;116(3):303-309.

 

 

2016

Bodgi L, Foray N. The nucleo-shuttling of the ATM protein as a basis for a novel theory of radiation response: resolution of the linear-quadratic model. Int J Radiat Biol. 2016;92(3):117-31.

COPERNIC project investigators, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, Rouvet I, Zabot MT, Joubert A, Vincent A, Dalla Venezia N, Bourguignon M, Canat EP, d'Hombres A, Thébaud E, Orbach D, Stoppa-Lyonnet D, Radji A, Doré E, Pointreau Y, Bourgier C, Leblond P, Defachelles AS, Lervat C, Guey S, Feuvret L, Gilsoul F, Berger C, Moncharmont C, de Laroche G, Moreau-Claeys MV, Chavaudra N, Combemale P, Biston MC, Malet C, Martel-Lafay I, Laude C, Hau-Desbat NH, Ziouéche A, Tanguy R, Sunyach MP, Racadot S, Pommier P, Claude L, Baleydier F, Fleury B, de Crevoisier R, Simon JM, Verrelle P, Peiffert D, Belkacemi Y, Bourhis J, Lartigau E, Carrie C, De Vathaire F, Eschwege F, Puisieux A, Lagrange JL, Balosso J, Foray N. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60.

Belkacemi Y, Colson-Durand L, Granzotto A, Husheng S, To NH, Majdoul S, Guet S, Hervé ML, Fonteneau G, Diana C, Le Bret C, Dominique C, Fayolle M, Foray N. The Henri Mondor Procedure of Morbidity and Mortality Review Meetings: Prospective Registration of Clinical, Dosimetric, and Individual Radiosensitivity Data of Patients With Severe Radiation Toxicity. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):629-36

Căpraru OM, Berger N, Gadot N, Decaussin-Petrucci M, Zhang C, Borda A, Szilágyi T, Borson-Chazot F, Selmi-Ruby S. Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases. Rom J Morphol Embryol. 57(1):91-8. 2016.

Theurey P, Tubbs E, Vial G, Jacquemetton J, Bendridi N, Chauvin MA, Alam MR, Le Romancer M, Vidal H, Rieusset J. Mitochondria-associated endoplasmic reticulum membranes allow adaptation of mitochondrial metabolism to glucose availability in the liver. J Mol Cell Biol. 2016 Apr;8(2):129-43

 

Goulvent T, Ray-Coquard I, Borel S, Haddad V, Devouassoux-Shisheboran M, Vacher-Lavenu MC, Pujade-Laurraine E, Savina A, Maillet D, Gillet G, Treilleux I, Rimokh R. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Histopathology. 2016 Jan;68(2):279-85.

Ferrari A, Vincent-Salomon A, Pivot X, Sertier AS, Thomas E, Tonon L, Boyault S, Mulugeta E, Treilleux I, MacGrogan G, Arnould L, Kielbassa J, Le Texier V, Blanché H, Deleuze JF, Jacquemier J, Mathieu MC, Penault-Llorca F, Bibeau F, Mariani O, Mannina C, Pierga JY, Trédan O, Bachelot T, Bonnefoi H, Romieu G, Fumoleau P, Delaloge S, Rios M, Ferrero JM, Tarpin C, Bouteille C, Calvo F, Gut IG, Gut M, Martin S, Nik-Zainal S, Stratton MR, Pauporté I, Saintigny P, Birnbaum D, Viari A, Thomas G.A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers. Nat Commun. 2016 Jul 13;7:12222.

 

Moutte A, Chopin N, Faure C, Beurrier F, Ho Quoc C, Guinaudeau F, Treilleux I, Carrabin N Surgical Management of Benign and Borderline Phyllodes Tumors of the Breast. Breast J. 2016 Sep;22(5):547-52.

 

Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X,Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M,Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA,Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA,Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, van't Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016 Jun 2;534(7605):47-54.

Azim HA, Kassem L, Treilleux I, Wang Q, El Enein MA, Anis SE, Bachelot T. Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast Cancer. Transl Oncol. 2016 Apr;9(2):114-123

2015

Clémenceau B, Valsesia-Wittmann S, Jallas AC, Vivien R, Rousseau R, Marabelle A, Caux C, Vié H. In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer. J Immunol Res. 2015:482089.

Duong MN, Cleret A, Matera EL, Chettab K, Mathé D, Valsesia-Wittmann S, Clémenceau B, Dumontet C. Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity. Breast Cancer Res. 2015 Apr 24;17:57.

Duong MN, Matera EL, Mathé D, Evesque A, Valsesia-Wittmann S, Clémenceau B, Dumontet C. Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies. MAbs. 2015;7(1):192-8.

Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, Valsesia-Wittmann S, Commo F, Prada N, Poirier-Colame V, Bressac B, Cotteret S, Brugieres L, Farace F, Chaput N, Kroemer G, Valteau-Couanet D, Zitvogel L. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Sci Transl Med. 2015 Apr 15;7(283):283ra55.

Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, Bénard J, Puisieux A, Marabelle A, Valsesia-Wittmann S. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma. Cancer Lett. 2015 Feb 1;357(1):412-8.

Bonnavion R, Teinturier R, Jaafar R, Ripoche D, Leteurtre E, Chen YJ, Rehfeld JF, Lepinasse F, Hervieu V, Pattou F, Vantyghem MC, Scoazec JY, Bertolino P and Zhang CX. Islet cells serve as cells of origin of pancreatic gastrin-positive endocrine tumours. Mol Cell Biol. PMID: 26169832, 35(19):3274-3283, 2015.

Ripoche D, Charbord J, Hennino A, Teinturier R, Bonnavion R, Jaafar R, Goehrig D, Cordier-Bussat M, Ritvos O, Zhang CX, Andersson O, Bertolino P. ActivinB Is Induced in Insulinoma To Promote Tumor Plasticity through a β-Cell-Induced Dedifferentiation. Mol Cell Biol. 36(5):756-64. 2015.

Feng Li, Yutong Su, Yulong Cheng, Xiuli Jiang, Ying Peng, Yanli Li, Jieli Lu, Yanyun Gu, Changxian Zhang, Yanan Cao, Weiqing Wang, Guang Ning. Conditional Deletion of Men1 in the Pancreatic beta-Cell Leads to Glucagon-Expressing Tumor. Endocrinology, 156(1): 48-57. 2015.

Poulard C, Rambaud J, Lavergne E, Jacquemetton J, Renoir JM, Trédan O, Chabaud S, Treilleux I, Corbo L, Le Romancer M. Role of JMJD6 in Breast Tumourigenesis. PLoS One. 2015 May 7;10(5):e0126181.

 

Dantas-Barbosa C, Lesluyes T, Loarer FL, Chibon F, Treilleux I, Coindre JM, Meeus P, Brahmi M, Bally O, Ray-Coquard I, Sunyach MP, Cesne AL, Mir O, Bonvalot S, Toulmonde M, Italiano A, Saintigny P, Jean-Denis M, Ducimetiere F, Ranchere D, El Sayadi H, Alberti L, Blay JY. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma. Br J Cancer. 2017 Dec 5;117(12):1787-1797

 

Desestret V, Chefdeville A, Viaccoz A, Bost C, Ducray F, Picard G, Rogemond V, Chaffois MO, Blanc C, Bardel C, Treilleux I, Pascual O, Antoine JC, Delattre JY, Honnorat J. CSF IgA NMDAR antibodies are potential biomarkers for teratomasin anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e166

Le Loarer F, Watson S, Pierron G, de Montpreville VT, Ballet S, Firmin N, Auguste A, Pissaloux D, Boyault S, Paindavoine S, Dechelotte PJ, Besse B, Vignaud JM, Brevet M, Fadel E, Richer W, Treilleux I, Masliah-Planchon J, Devouassoux-Shisheboran M, Zalcman G, Allory Y, Bourdeaut F, Thivolet-Bejui F, Ranchere-Vince D, Girard N, Lantuejoul S, Galateau-Sallé F, Coindre JM, Leary A, Delattre O, Blay JY, Tirode F. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat Genet. 2015 Oct;47(10):1200-5

Couder F, Schmitt C, Treilleux I, Tredan O, Faure C, Carrabin N, Beurrier F, Chopin N. [Axillary lymph node metastases with an occult breast: About 16 cases from a cohort of 7770 patients]. Gynecol Obstet Fertil. 2015 Sep;43(9):588-92.

Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, Chabaud S, Carrabin N, Chopin N, Bachelot T, Gillet G, Treilleux I, Rimokh R. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. BMC Cancer. 2015 Jun 4;15:453.

Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M; ICGC Prostate Cancer Working Group; ICGC Bone Cancer Working Group; ICGC Breast Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, van't Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova SG, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 2015 Jun;25(6):814-24.

Leyland-Jones B, Gray KP, Abramovitz M, Bouzyk M, Young B, Long B, Kammler R, Dell'Orto P, Biasi MO, Thürlimann B, Lyng MB, Ditzel HJ, Harvey VJ, Neven P, Treilleux I, Rasmussen BB, Maibach R, Price KN, Coates AS, Goldhirsch A, Pagani O, Viale G, Rae JM, Regan MM. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Breast Cancer Res Treat. 2015 Jun;151(2):373-84

Emin L, Meeus P, Beurrier F, Ferraioli D, Carrabin N, Ray-Coquard I, Treilleux I, Chopin N. [Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer]. Gynecol Obstet Fertil. 2015 May;43(5):342-7.

François CM, Wargnier R, Petit F, Goulvent T, Rimokh R, Treilleux I, Ray-Coquard I, Zazzu V, Cohen-Tannoudji J, Guigon CJ. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomicmechanism involving GPER1. Carcinogenesis. 2015 May;36(5):564-73.

Chapellier M, Bachelard-Cascales E, Schmidt X, Clément F, Treilleux I, Delay E, Jammot A, Ménétrier-Caux C, Pochon G, Besançon R, Voeltzel T, Caron de Fromentel C, Caux C, Blay JY, Iggo R, Maguer-Satta V. Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response. Stem Cell Reports. 2015 Feb 10;4(2):239-54.

2014

 

Ferlazzo ML, Sonzogni L, Granzotto A, Bodgi L, Lartin O, Devic C, Vogin G, Pereira S, Foray N. Mutations of the Huntington's disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates. Mol Neurobiol. 2014 Jun;49(3):1200-11.

 

Poulard C, Rambaud J, Le Romancer M, Corbo L. Proximity ligation assay to detect and localize the interactions of ERα with PI3-K and Src in breast cancer cells and tumor samples. Methods Mol Biol. 2014;1204:135-43.

 

Nguyen NT, Vendrell JA, Poulard C, Győrffy B, Goddard-Léon S, Bièche I, Corbo L, Le Romancer M, Bachelot T, Treilleux I, Cohen PA. A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers. Mol Oncol. 2014 Dec;8(8):1441-57.

 

Xiuli Jiang, Yanan Cao, Feng Li, Yutong Su, Yanli Li, Ying Peng, Yulong Cheng, Chang-xian Zhang, Weiqing Wang & Guang Ning. Targeting β-Catenin Signaling for Therapeutic Intervention in MEN1-Deficient Pancreatic Neuroendocrine Tumours. Nature Communication. 5:5809. 2014.

Jieli Lu, Rami Jaafer, Rémy Bonnavion, Philippe Bertolino and Chang-Xian Zhang. Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms. World J Diabetes, 5(6):847-53. 2014.

Bouchekioua-Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, Bachelot T, Chabaud S, Mader S, Dayan G, Treilleux I, Corbo L, Le Romancer M. LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer. Int J Cancer. 2014 Sep 15;135(6):1307-18.

 

Poulard C, Rambaud J, Hussein N, Corbo L, Le Romancer M JMJD6 regulates ERα methylation on arginine.PLoS One. 2014 Feb 3;9(2):e87982.

 

MacGrogan G, Mathieu MC, Poulet B, Penault-Llorca F, Vincent-Salomon A, Roger bP, Treilleux I, Valent A, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M; GEFPICS. [Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France]. Ann Pathol. 2014 Oct;34(5):366-72.

Penault-Llorca F, Vincent-Salomon A, MacGrogan G, Roger P, Treilleux I, Valent A, Mathieu MC, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Poulet B, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M; GEFPICS. [2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]. AnnPathol. 2014 Oct;34(5):352-65.

Treilleux I, Arnedos M, Cropet C, Wang Q, Ferrero JM, Abadie-Lacourtoisie S, Levy C, Legouffe E, Lortholary A, Pujade-Lauraine E, Bourcier AV, Eymard JC,Spaeth D, Bachelot T. Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer. Ann Oncol. 2015 26(1):120-5.

Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, Menzies A, Roman-Garcia P, Fullam A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E, Knappskog S, Van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP, Nik-Zainal S, Alexandrov L, Behjati S, Yates LR, Bolli N, Mudie L, Hardy C, Martin S, McLaren S, O'Meara S, Anderson E, Maddison M, Gamble S, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C, Neal D, Lynch AG, Visakorpi T, Isaacs WB, Veer LV, Caldas C, Desmedt C, Sotiriou C, Aparicio S, Foekens JA, Eyfjörd JE, Lakhani SR, Thomas G, MyklebostO, Span PN, Børresen-Dale AL, Richardson AL, Van de Vijver M, Vincent-Salomon A, Van den Eynden GG, Flanagan AM, Futreal PA, Janes SM, Bova GS, Stratton MR, McDermott U, Campbell PJ; ICGC Breast Cancer Group; ICGC Bone Cancer Group; ICGC Prostate Cancer Group. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 2014 Aug 1;345(6196):1251343.

Cooke SL, Shlien A, Marshall J, Pipinikas CP, Martincorena I, Tubio JM, Li Y, Menzies A, Mudie L, Ramakrishna M, Yates L, Davies H, Bolli N, Bignell GR, Tarpey PS, Behjati S, Nik-Zainal S, Papaemmanuil E, Teixeira VH, Raine K, O'Meara S, Dodoran MS, Teague JW, Butler AP, Iacobuzio-Donahue C, Santarius T, Grundy RG, Malkin D, Greaves M, Munshi N, Flanagan AM, Bowtell D, Martin S, Larsimont D,Reis-Filho JS, Boussioutas A, Taylor JA, Hayes ND, Janes SM, Futreal PA, Stratton MR, McDermott U, Campbell PJ; ICGC Breast Cancer Group. Processed pseudogenesacquired somatically during cancer development. Nat Commun. 2014 Apr 9;5:3644.

Caplain A, Drouet Y, Peyron M, Peix M, Faure C, Chassagne-Clément C, Beurrier F, Fondrevelle ME, Guérin N, Lasset C, Treilleux I. Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution. Am J Surg. 2014 Aug;208(2):260-7.

Cassier PA, Floquet A, Penel N, Derbel O, Bui N'guyen B, Guastalla JP, Pissaloux D, Treilleux I, Saba CE, Blay JY, Ray-Coquard I. The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors. Ann Oncol. 2014 May;25(5):1074-5

Maillet L, Chopin N, Treilleux I, Bachelot T, Tredan O, Faure C, Caux C,Beurrier F. [Spontaneous regression of breast cancer after biopsy. About twocases]. Gynecol Obstet Fertil. 2014 Apr;42(4):269-72.

 

Pôle d'Unité “DEFENSE” 

2020

Ostheim P, Haupt J, Herodin F, Valente M, Drouet M, Majewski M, Port M, Abend M. miRNA Expression Patterns Differ by Total- or Partial-Body Radiation Exposure in Baboons. Radiat Res. 2019 Dec;192(6):579-588. doi: 10.1667/RR15450.1. Epub 2019 Sep 26.

Habauzit D, Nugue G, Bourbon F, Martin C, Del Vecchio F, Maunoir-Regimbal S, Poyot T, Valente M, Jaoui R, Crouzier D, Le Dréan Y, Debouzy JC. Evaluation of the Effect of Chronic 94 GHz Exposure on Gene Expression in the Skin of Hairless Rats In Vivo. Radiat Res. 2020 Mar 3. doi: 10.1667/RR15470.1.

Bosquillon de Jenlis A, Del Vecchio F, Delanaud S, Bach V, Pelletier A. Effects of co-exposure to 900 MHz radiofrequency electromagnetic fields and high-level noise on sleep, weight, and food intake parameters in juvenile rats. Environ Pollut. 2020 Jan;256:113461. doi: 10.1016/j.envpol.2019.113461. Epub 2019 Oct 25.

2019

Bolduc DL, Blakely WF, H Olsen C, Agay D, Mestries JC, Drouet M, Hérodin F. Baboon radiation quality (mixed-field neutron and gamma, gamma alone) dose-response model systems: assessment of H-ARS severity unsing haematologic biomarkers. Radiat Prot Dosimetry. 2019 Dec 31;186(1):15-23.

 

2018

Port M, Hérodin F, Valente M, Drouet M, Ostheim P, Majewski M, Abend M. Persistent mRNA and miRNA expression changes in irradiated baboons. Sci Rep. 2018 Oct 18;8(1):15353.

 

Riccobono D, Nikovics K, François S, Favier AL, Jullien N, Schrock G, Scherthan H, Drouet M. First Insights Into the M2 Inflammatory Response After Adipose-Tissue-Derived Stem Cell Injections in Radiation-Injured Muscles. Health Phys. 2018 Jul;115(1):37-48.

 

Blakely WF, Bolduc DL, Debad J, Sigal G, Port M, Abend M, Valente M, Drouet M, Hérodin F. Use of Proteomic and Hematology Biomarkers for Prediction of Hematopoietic Acute Radiation Syndrome Severity in Baboon Radiation Models. Health Phys. 2018 Jul;115(1):29-36.

 

Port M, Majewski M, Herodin F, Valente M, Drouet M, Forcheron F, Tichy A, Sirak I, Zavrelova A, Malkova A, Becker BV, Veit DA, Waldeck S, Badie C, O'Brien G, Christiansen H, Wichmann J, Eder M, Beutel G, Vachelova J, Doucha-Senf S, Abend M. Validating Baboon Ex Vivo and In Vivo Radiation-Related Gene Expression with Corresponding Human Data. Radiat Res. 2018 Apr;189(4):389-398.

 

Bensimon Etzol J, Valente M, Altmeyer S, Bettencourt C, Bouvet S, Cosler G, Desangles F, Drouet M, Entine F, Hérodin F, Jourquin F, Lecompte Y, Martigne P, Michel X, Pateux J, Ugolin N, Chevillard S. DosiKit, a New Portable Immunoassay for Fast External Irradiation Biodosimetry. Radiat Res. 2018 Aug;190(2):176-185.

2017

Port M, Hérodin F, Valente M, Drouet M, Ullmann R, Majewski M, Abend M. Pre-Exposure Gene Expression in Baboons with and without Pancytopenia after Radiation Exposure.Int J Mol Sci. 2017 Mar 2;18(3).

Port M, Hérodin F, Valente M, Drouet M, Lamkowski A, Majewski M, Abend M. Gene expression signature for early prediction of late occurring pancytopenia in irradiated baboons. Ann Hematol. 2017 May;96(5):859-87.

Dörr H, Abend M, Blakely WF, Bolduc DL, Boozer D, Costeira T, Dant T, De Amicis A, De Sanctis S, Dondey M, Drouet M, Entine F, Francois S, Gagna G, Guitard N, Hérodin F, Hoefer M, Lamkowski A, La Sala G, Lista F, Loiacono P, Majewski M, Martigne P, Métivier D, Michel X, Pateux J, Pejchal J, Reeves G, Riccobono D, Sinkorova Z, Soyez L, Stricklin D, Tichy A, Valente M, Woodruff CR Jr, Zarybnicka L, Port M. Using Clinical Signs and Symptoms for Medical Management of Radiation Casualties - 2015 NATO Exercise. Radiat Res. 2017 Mar;187(3):273-286.

2016

Port M, Herodin F, Valente M, Drouet M, Ullmann R, Doucha-Senf S, Lamkowski A, Majewski M, Abend M.MicroRNA Expression for Early Prediction of Late Occurring Hematologic Acute Radiation Syndrome in Baboons. PLoS One. 2016 Nov 15;11(11):e0165307.

Port M, Herodin F, Valente M, Drouet M, Lamkowski A, Majewski M, Abend M. First Generation Gene Expression Signature for Early Prediction of Late Occurring Hematological Acute Radiation Syndrome in Baboons. Radiat Res. 2016 Jul;186(1):39-54.

Riccobono D, Agay D, François S, Scherthan H, Drouet M, Forcheron F. Contribution of INTRAMUSCULAR Autologous Adipose Tissue-Derived Stem Cell Injections to Treat Cutaneous Radiation Syndrome: Preliminary Results. Health Phys. 2016 Aug;111(2):117-26.

Hérodin F, Voir D, Vilgrain I, Courçon M, Drouet M, Boittin FX. Soluble Vascular Endothelial Cadherin as a New Biomarker of Irradiation in Highly Irradiated Baboons with Bone Marrow Protection. Health Phys. 2016 Jun;110(6):598-605.

Rancoule C, Magné N, Vallard A, Guy JB, Rodriguez-Lafrasse C, Deutsch E, Chargari C. Nanoparticles in radiation oncology: From bench-side to bedside. Cancer Lett. 2016 Jun 1;375(2):256-62.

2015

Valente M, Denis J, Grenier N, Arvers P, Foucher B, Desangles F, Martigne P, Chaussard H, Drouet M, Abend M, Hérodin F. Revisiting Biomarkers of Total-Body and Partial-Body Exposure in a Baboon Model of Irradiation.PLoS One. 2015 Jul 15;10(7):e0132194

Boittin FX, Martigne P, Mayol JF, Denis J, Raffin F, Coulon D, Grenier N, Drouet M, Hérodin F. Experimental Quantification of Delayed Radiation-Induced Organ Damage in Highly Irradiated Rats With Bone Marrow Protection: Effect of Radiation Dose and Organ Sensitivity. Health Phys. 2015 Aug;109(2):134-44

Boittin FX, Denis J, Mayol JF, Martigne P, Raffin F, Coulon D, Grenier N, Drouet M, Hérodin F. The extent of irradiation-induced long-term visceral organ damage depends on cranial/brain exposure. PLoS One. 2015 Apr 2;10(4):e0122900.

Mazeron R, Maroun P, Castelnau-Marchand P, Dumas I, del Campo ER, Cao K, Slocker-Escarpa A, M'Bagui R, Martinetti F, Tailleur A, Guemnie-Tafo A, Morice P, Chargari C, Lefkopoulos D, Haie-Meder C. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder. Radiother Oncol. 2015 Aug;116(2):226-32

2014

Riccobono D, Forcheron F, Agay D, Scherthan H, Meineke V, Drouet M. Transient gene therapy to treat cutaneous radiation syndrome: development in a minipig model. Health Phys. 2014 Jun;106(6):713-9.

 

Lamkowski A, Forcheron F, Agay D, Ahmed EA, Drouet M, Meineke V, Scherthan H. DNA damage focus analysis in blood samples of minipigs reveals acute partial body irradiation. PLoS One. 2014 Feb 3;9(2):e87458.

 

Drouet M, Garrigou P, Peinnequin A, Hérodin F. Short-term sonic-hedgehog gene therapy to mitigate myelosuppression in highly irradiated monkeys: hype or reality? Bone Marrow Transplant. 2014 Feb;49(2):304-9.  

 

 

Pôle d'Unité “SANTE”

Devic, C. Berthel E., Ferlazzo , ML Foray N. Influence of individual radiosensitivity on the hormesis phenomenon: towards a mechanistic explanation based on the nucleo-shuttling of ATM protein. Dose-response, in press

Leroy R, Silversmit G, Stordeur S, De Gendt C, Verleye L, Schillemans V, Savoye I, Van Eycken L, Deron P, Hamoir M, Vermorken J, Grégoire V, Nuyts S. Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium. Eur J Cancer. 2020 Mar 13;130:81-91. doi: 10.1016/j.ejca.2020.01.024. [Epub ahead of print]

Stordeur S, Schillemans V, Savoye I, Vanschoenbeek K, Leroy R, Macq G, Verleye L, De Gendt C, Nuyts S, Vermorken J, Beguin C, Grégoire V, Van Eycken L. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? Oral Oncol. 2020 Jan 7;102:104561.

Podeur F, Pommier P, Crozes C, Monchet E, Ton Van J, Roux PE, Poupart M, Zrounba P, Julieron M, Deneuve S. Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes. Head Neck. 2020 Feb;42(2):302-311. doi: 10.1002/hed.26007. Epub 2019 Nov 18.

Pasquier D, Peiffert D, Nickers P, Maingon P, Pommier P, Lacornerie T, Martinage G, Tresch E, Lartigau E. A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):116-123.

Martin-Broto J, Hindi N, Lopez-Pousa A, Peinado-Serrano J, Alvarez R, Alvarez-Gonzalez A, Italiano A, Sargos P, Cruz-Jurado J, Isern-Verdum J, Dolado MC, Rincon-Pérez I, Sanchez-Bustos P, Gutierrez A, Romagosa C, Morosi C, Grignani G, Gatti M, Luna P, Alastuey I, Redondo A, Belinchon B, Martinez-Serra J, Sunyach MP, Coindre JM, Dei Tos AP, Romero J, Gronchi A, Blay JY, Moura DS. Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial. JAMA Oncol. 2020 Feb 20.

Aust S, Eberst L, Tredan O, Rousset-Jablonski C, Treilleux I, Méeus P, Chopin N, Beurrier F, Charreton A, Véronique D, Hallouz A, Coulon A, Ricoeur A, Mastier C, Bouhamama A, Racadot S, Devouassoux-Shisheboran M, Haddad V, Ray-Coquard I. Detailed overview on rare malignant ovarian tumors. Bull Cancer. 2020 Mar;107(3):385-390

Biston MC, Jarril J, Dupuis P, Boisbouvier S, Gassa F, Cervellera M, Chabaud S, Racadot S.Comparison among four immobilization devices for whole breast irradiation with Helical Tomotherapy. Phys Med. 2020 Jan;69:205-211.

Graff P, Blanchard P, Thariat J, Racadot S, Lapeyre M. [Post-treatment follow-up of head and neck cancer patients]. Cancer Radiother. 2019 Oct;23(6-7):576-580.

Dumont B, Fresneau B, Claude L, Defachelles AS, Couloigner V, Puget S, Brisse HJ, Fréneaux P, Lacour B, Orbach D.Pattern of loco-regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (Fracture) contribution. Pediatr Blood Cancer. 2020 Apr;67(4):e28154.

2019

Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, Guinbretiere JM, Hauser P, Hjorth L, Janeway K, Juergens H, Judson I, Krailo M, Kruseova J, Kuehne T, Ladenstein R, Lervat C, Lessnick SL, Lewis I, Linassier C, Marec-Berard P, Marina N, Morland B, Pacquement H, Paulussen M, Randall RL, Ranft A, Le Teuff G, Wheatley K, Whelan J, Womer R, Oberlin O, Hawkins DS; Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J Clin Oncol. 2019 Dec 1;37(34):3192-3202.

Stelmes JJ, Gregoire V, Poorten VV, Golusiñski W, Szewczyk M, Jones T, Ansarin M, Broglie MA, Giger R, Klussmann JP, Evans M, Bourhis J, Leemans CR, Spriano G, Dietz A, Hunter K, Zimmermann F, Tinhofer I, Patterson JM, Quaglini S, Govaerts AS, Fortpied C, Simon C. Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the "Best of" Trial. Front Oncol. 2019 Oct 22;9:999..

Biston MC, Dupuis P, Gassa F, Grégoire V. Do all the linear accelerators comply with the ICRU 91's constraints for stereotactic body radiation therapy treatments? Cancer Radiother. 2019 Oct;23(6-7):625-629.

Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Chan Ahn Y, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT. International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33428-5.

Jamme P, Descarpentries C, Gervais R, Dansin E, Wislez M, Grégoire V, Richard N, Baldacci S, Rabbe N, Kyheng M, Kherrouche Z, Escande F, Copin MC, Cortot AB. Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice. Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30063-4.

Wirth LJ, Burtness B, Nathan CO, Grégoire V, Richmon J. Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How? Am Soc Clin Oncol Educ Book. 2019 Jan;39:364-372.

Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, Kazmierska J, Langendijk JA, Ozsahin M, O'Sullivan B, Bourhis J, Grégoire V. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019 May;134:1-9.

Beyaert S, Hamoir M, Van Maanen A, Grégoire V, Schmitz S. Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma. Eur J Surg Oncol. 2019 Jul;45(7):1188-1195.

Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A, Hofmeister D, Krejovic Trivic S, Loo S, Chie WC, Bjordal K, Brokstad Herlofson B, Grégoire V, Licitra L; EORTC Quality of Life and the EORTC Head and Neck Cancer Groups. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head Neck. 2019 Jun;41(6):1725-1737.

Tol JP, Dahele M, Gregoire V, Overgaard J, Slotman BJ, Verbakel WFAR Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. Radiother Oncol. 2019 Jan;130:75-81.

Maignan M, Viglino D, Collomb Muret R, Vejux N, Wiel E, Jacquin L, Laribi S, N-Gueye P, Joly LM, Dumas F, Beaune S; IRU-SFMU Group. Intensity of care delivered by prehospital emergency medical service physicians to patients with deliberate self-poisoning: results from a 2-day cross-sectional study in France. Intern Emerg Med. 2019 May 18.

Biston MC, Zaragori T, Delcoudert L, Fargier-Voiron M, Munoz A, Gorsse C, Sarrut D, Pommier P. Comparison of electromagnetic transmitter and ultrasound imaging for intrafraction monitoring of prostate radiotherapy. Radiother Oncol. 2019 Jul;136:1-8.

Vaugier L, Palpacuer C, Rio E, Goineau A, Pasquier D, Buthaud X, De Laroche G, Beckendorf V, Sargos P, Créhange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Campion L, Supiot S. Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07). Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1061-1067.

Gronchi A, Hindi N, Cruz J, Blay JY, Lopez-Pousa A, Italiano A, Alvarez R, Gutierrez A, Rincón I, Sangalli C, Pérez Aguiar JL, Romero J, Morosi C, Sunyach MP, Sanfilippo R, Romagosa C, Ranchere-Vince D, Dei Tos AP, Casali PG,

Martin-Broto J. Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups. EClinicalMedicine. 2019 Mar 11;9:35-43.

Carbonnaux M, Brahmi M, Schiffler C, Meeus P, Sunyach MP, Bouhamama A, Karanian M, Tirode F, Pissaloux D, Vaz G, Ray-Coquard I, Blay JY, Dufresne A. Very long-term survivors among patients with metastatic soft tissue sarcoma. Cancer Med. 2019 Apr;8(4):1368-1378.

Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E. Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging. BMC Cancer. 2019 Feb 21;19(1):167.

Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L, Muracciole X, Supiot S, Huchet A, Leseur J, Kerr C, Hangard G, Lisbona A, Goudjil F, Ferrand R, Laprie A. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Front Oncol. 2019 Jun 21;9:531.

Jouin A, Helfre S, Bolle S, Claude L, Laprie A, Bogart E, Vigneron C, Potet H, Ducassou A, Claren A, Riet FG, Castex MP, Faure-Conter C, Fresneau B, Defachelles AS, Orbach D. Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience. Strahlenther Onkol. 2019 Jun;195(6):504-516.

Régnier E, Laprie A, Ducassou A, Bolle S, Supiot S, Muracciole X, Claude L, Chapet S, Coche-Dequéant B, Vigneron C, Leseur J, Bondiau PY, Habrand JL, Bernier V. Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children's cancer. Radiother Oncol. 2019 Mar;132:1-7.

Visy A, Bachelot T, Racadot S.Radiation recall syndrome in a patient with breast cancer, after introduction of everolimus. Cancer Radiother. 2019 Jun 5.

Crombé A, Alberti N, Villard N, Pilleul F, Buy X, Le Loarer F, Kind M. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients. Eur Radiol. 2019 Feb 14.

Colin C, Delov AG, Peyron-Faure N, Rabilloud M, Charlot M. Breast abscesses in lactating women: evidences for ultrasound-guided percutaneous drainage to avoid surgery. Emerg Radiol. 2019 Jun 1.

Bournaud C, Descotes F, Decaussin-Petrucci M, Berthiller J, de la Fouchardière C, Giraudet AL, Bertholon-Gregoire M, Robinson P, Lifante JC, Lopez J, Borson-Chazot F. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma. Eur J Cancer. 2019 Feb;108:41-49.

Bachelet JT, Adnot J, Termont A, Decaudaveine S, Paulus C. [Short osteotomy use in orthognathic surgery: benefit, disadvantage and perspective]. Orthod Fr. 2019 Jun;90(2):161-168.

Pegat A, Ducray F, Jeannin-Mayer S, Jouanneau E, Pinson S, Petiot P. Charcot-Marie-Tooth (CMT)-like polyneuropathy revealing neurofibromatosis type 2: A case report and review of the literature. Rev Neurol (Paris). 2019 Jun 17. pii: S0035-3787(18)30766-5.

Calender A, Lim CX, Weichhart T, Buisson A, Besnard V, Rollat-Farnier PA, Bardel C, Roy P, Cottin V, Devouassoux G, Finat A, Pinson S, Lebecque S, Nunes H, Israel-Biet D, Bentaher A, Valeyre D, Pacheco Y; in the frame of GSF (Group Sarcoidosis France). Exome sequencing and pathogenicity-network analysis of 5 French families implicate mTOR signalling and autophagy in familial sarcoidosis. Eur Respir J. 2019 Apr 25. pii: 1900430

El Hachem N, Abadie C, Longy M, Colas C, Fert-Ferrer S, Leroux D, Grandval P, Prieur F, Collonge-Rame M, Faivre L, Fricker JP, Zerbib F, Coupier I, Cauchin E, Pinson S, Saurin JC. Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study. Dis Colon Rectum. 2019 Apr;62(4):470-475.

2018

Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee A, Maingon P, Mäkitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Składowski K, Tribius S, Waldron J, Wee J, Yao M, Yom SS, Zimmermann F, Grau C. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018 Jan;126(1):3-24.

Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao Y, Yom SS, Wee JT. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2018 Jan;126(1):25-36.

Grégoire V, Grau C, Lapeyre M, Maingon P Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.Oral Oncol. 2018 Dec;87:131-137.

Doix B, Bastien E, Rambaud A, Pinto A, Louis C, Grégoire V, Riant O, Feron O. Preclinical Evaluation of White Led-Activated Non-porphyrinic Photosensitizer OR141 in 3D Tumor Spheroids and Mouse Skin Lesions.Front Oncol. 2018 Sep 21;8:393

Descarpentries C, Leprêtre F, Escande F, Kherrouche Z, Figeac M, Sebda S, Baldacci S, Grégoire V, Jamme P, Copin MC, Tulasne D, Cortot AB. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients. J Thorac Oncol. 2018 Dec;13(12):1873-1883.

Mignion L, Schmitz S, Michoux N, Caignet X, Goebbels RM, Bol A, Neveu MC, Grégoire V, Duprez T, Lhommel R, Amant F, Hermans E, Jordan BF, Machiels JP. 2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck. Oncotarget. 2018 Jun 19;9(47):28572-28585.

Grégoire V. Multi-modal imaging for dose planning and its benefits: the paradigm of head and neck tumours.Ann ICRP. 2018 Oct;47(3-4):159.

Schneider K, Marbaix E, Bouzin C, Hamoir M, Mahy P, Bol V, Grégoire V. Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study. Acta Oncol. 2018 Sep;57(9):1165-1172.

Mathis T, Levron A, Pommier P, Denis P, Thariat J, Kodjikian L. Intra- and subretinal neovascularization following radiation therapy: Contribution of OCT-angiography. J Fr Ophtalmol. 2018 Dec;41(10):e481-e483.

De Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL. Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429.

Supiot S, Campion L, Pommier P, Dore M, Palpacuer C, Racadot S, Rio E, Milano GA, Mahier-Ait Oukhatar C, Carrie C. Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP. Oncotarget. 2018 Apr 24;9(31):22147-22157.

Boughzala-Bennadji R, Stoeckle E, Le Péchoux C, Méeus P, Honoré C, Attal J, Duffaud F, De Pinieux G, Bompas E, Thariat J, Leroux A, Bertucci F, Isambert N, Delcambre C, Blay JY, Sunyach MP, Coindre JM, Sargos P, Penel N, Bonvalot S. Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):399-406.

Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, Moureau Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Laigre M, Guillemet C, Salas S, Hugli A, Domont J, Sunyach MP, Lecesne A, Blay JY, Nerich V, Isambert N. Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO). Oncologist. 2018 Aug;23(8):948-955.

Rasmussen V, Forrest LE, Rogasik M, Girodet M, Meeus P, Sunyach MP, Blay JY, Bally O, Brahmi M, Ballinger ML, Niedermayr E, Thomas DM, Halliday J, James P, Ray-Coquard I, Young MA; International Sarcoma Kindred Study. A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findings. Per Med. 2018 Jan;15(1):13-24.

Sargos P, Charleux T, Haas RL, Michot A, Llacer C, Moureau-Zabotto L, Vogin G, Le Péchoux C, Verry C, Ducassou A, Delannes M, Mervoyer A, Wiazzane N, Thariat J, Sunyach MP, Benchalal M, Laredo JD, Kind M, Gillon P, Kantor G. Pre- and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation oncologists. Cancer Radiother. 2018 Apr;22(2):131-139.

Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner V, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen TD, Bertozzi AI, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A; Pediatric French Radiation Oncologist Group (GFRP) and the French Society of Children With Cancer (SFCE). Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013. Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):166-173.

Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Laprie A; French Society for Childhood Cancer (SFCE). Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma. Radiother Oncol. 2018 Apr;127(1):103-107.

Demoor-Goldschmidt C, Supiot S, Mahé MA, Oberlin O, Allodji R, Haddy N, Helfre S, Vigneron C, Brillaud-Meflah V, Bernier V, Laprie A, Ducassou A, Claude L, Diallo I, de Vathaire F.Clinical and histological features of second breast cancers following radiotherapy for childhood and young adult malignancy.Br J Radiol. 2018 Jun;91(1086):20170824.

Padovani L, Chapon F, André N, Boucekine M, Geoffray A, Bourdeau F, Masliah-Planchon J, Claude L, Huchet A, Laprie A, Supiot S, Coche-Dequéant B, Kerr C, Alapetite C, Leseur J, Nguyen T, Chapet S, Bernier V, Bondiau PY, Noel G, Habrand JL, Bolle S, Doz F, Dufour C, Muracciole X, Carrie C. Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases? Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):980-986.

Jouglar E, Isnardi V, Goulon D, Ségura-Ferlay C, Ayadi M, Dupuy C, Douillard JY, Mahé MA, Claude L. Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial. Radiother Oncol. 2018 Feb;126(2):291-299.

Tao Y, Auperin A, Sire C, Martin L, Khoury C, Maingon P, Bardet E, Kaminsky MC, Lapeyre M, Chatellier T, Alfonsi M, Pointreau Y, Jadaud E, Géry B, Zawadi A, Tourani JM, Laguerre B, Coutte A, Racadot S, Hasbini A, Malaurie E, Borel C, Meert N, Cornely A, Ollivier N, Casiraghi O, Sun XS, Bourhis J. Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial. J Clin Oncol. 2018 Jun 7:JCO2017762518.

Tao Y, Faivre L, Laprie A, Boisselier P, Ferron C, Jung GM, Racadot S, Gery B, Even C, Breuskin I, Bourhis J, Janot F. Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab. Radiother Oncol. 2018 Sep;128(3):467-471.

Frikha M, Auperin A, Tao Y, Elloumi F, Toumi N, Blanchard P, Lang P, Sun S, Racadot S, Thariat J, Alfonsi M, Tuchais C, Cornely A, Moussa A, Guigay J, Daoud J, Bourhis J; GORTEC A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02). Ann Oncol. 2018 Mar 1;29(3):731-736.

Delerce C, Bailly O, Bouhamama A, Couchon S, Pilleul F, Thivolet A, Mastier C. Descending thoracic aortic aneurysm revealing metastasis of a soft tissue fibrosarcoma: a case report and review of the literature. Clin Sarcoma Res. 2018 Oct 26;8:22.

Thibaut A, Bouhamama A, Boespflug A, Vaz G, Cuinet M, Kalenderian AC, Menassel B, Ricoeur A, Mastier C, Pilleul F. Percutaneous Cryotherapy for Treatment of Chondroblastoma: Early Experience. Cardiovasc Intervent Radiol. 2019 Feb;42(2):304-307.

Cartier V, Crouan A, Esvan M, Oberti F, Michalak S, Gallix B, Seror O, Paisant A, Vilgrain V, Aubé C; CHIC group. Suspicious liver nodule in chronic liver disease: Usefulness of a second biopsy. Diagn Interv Imaging. 2018 Jul - Aug;99(7-8):493-499

Beji H, Pilleul F, Picard R, Tredan O, Bouhamama A, Peix M, Mavrovi E, Mastier C. Percutaneous cryoablation of breast tumours in patients with stable metastatic breast cancer: safety, feasibility and efficacy.Br J Radiol. 2018 Feb;91(1083):20170500.

Thivolet A, Menassel B, Chatté G, Tabutin M, Bouhamama A, Pilleul F, Mastier C. Delayed Bronchocutaneous Fistula Without Pneumothorax Following a Microwave Ablation of a Recurrent Pulmonary Metastasis.Cardiovasc Intervent Radiol. 2018;41(2):340-343.

Gjorgjievska Delov A, Farrou G, Bouhamama A, Pilleul F, Mastier C. Tumoral Dissemination Along the Screw Trajectory in Percutaneous Osteosynthesis and Cementoplasty: A Non-described Complication. Cardiovasc Intervent Radiol. 2018 Feb;41(2):336-339.

Banaste N, Caurier B, Bratan F, Bergerot JF, Thomson V, Millet I. Whole-Body CT in Patients with Multiple Traumas: Factors Leading to Missed Injury. Radiology. 2018 Nov;289(2):374-383.

Banaste N, Rousset P, Mercier F, Rieussec C, Valette PJ, Glehen O, Passot G. Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. Int J Hyperthermia. 2018 Aug;34(5):589-594

Evans A, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PA, Bick U, Camps Herrero J, Clauser P, Colin C, Cornford E, Fallenberg EM, Fuchsjaeger MH, Gilbert FJ, Helbich TH, Kinkel K, Heywang-Köbrunner SH, Kuhl CK, Mann RM, Martincich L, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Zackrisson S, Forrai G, Sardanelli F; European Society of Breast Imaging (EUSOBI) , with language review by Europa Donna–The European Breast Cancer Coalition. Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging. 2018 Aug;9(4):449-461.

 

Giraudet AL, Cassier PA, Iwao-Fukukawa C, Garin G, Badel JN, Kryza D, Chabaud S, Gilles-Afchain L, Clapisson G, Desuzinges C, Sarrut D, Halty A, Italiano A, Mori M, Tsunoda T, Katagiri T, Nakamura Y, Alberti L, Cropet C, Baconnier S, Berge-Montamat S, Pérol D, Blay JY. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 8;18(1):646.

De la Fouchardière C, Decaussin-Petrucci M, Berthiller J, Descotes F, Lopez J, Lifante JC, Peix JL, Giraudet AL, Delahaye A, Masson S, Bournaud-Salinas C, Borson Chazot F. Predictive factors of outcome in poorly differentiated thyroid carcinomas. Eur J Cancer. 2018 Mar;92:40-47.

Schroyen S, Adam S, Marquet M, Jerusalem G, Thiel S, Giraudet AL, Missotten P. Communication of healthcare professionals: Is there ageism? Eur J Cancer Care (Engl). 2018 Jan;27(1).

Bachelet JT, Cordier G, Porcheray M, Bourlet J, Gleizal A, Foletti JM. Orbital Reconstruction by Patient-Specific Implant Printed in Porous Titanium: A Retrospective Case Series of 12 Patients. J Oral Maxillofac Surg. 2018 Oct;76(10):2161-2167.

Lear JT, Migden MR, Lewis KD, Chang ALS, Guminski A, Gutzmer R, Dirix L, Combemale P, Stratigos A, Plummer R, Castro H, Yi T, Mone M, Zhou J, Trefzer U, Kaatz M, Loquai C, Kudchadkar R, Sellami D, Dummer R. Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study. J Eur Acad Dermatol Venereol. 2018 Mar;32(3):372-381.

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N; in the frame of GSF (Groupe Sarcoïdose France). Whole exome sequencing in three families segregating a pediatric case of sarcoidosis. BMC Med Genomics. 2018 Mar 6;11(1):23. 

2017

Schneider K, Bol V, Grégoire V.Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines. Radiother Oncol. 2017 Sep;124(3):411-417.

Lacas B, Bourhis J, Overgaard J, Zhang Q, Grégoire V, Nankivell M, Zackrisson B, Szutkowski Z, Suwiński R, Poulsen M, O'Sullivan B, Corvò R, Laskar SG, Fallai C, Yamazaki H, Dobrowsky W, Cho KH, Beadle B, Langendijk JA, Viegas CMP, Hay J, Lotayef M, Parmar MKB, Aupérin A, van Herpen C, Maingon P, Trotti AM, Grau C, Pignon JP, Blanchard P; MARCH Collaborative Group. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 2017 Sep;18(9):1221-1237.

Tao Y, Aupérin A, Graff P, Lapeyre M, Grégoire V, Maingon P, Geoffrois L, Verrelle P, Calais G, Gery B, Martin L, Alfonsi M, Deprez P, Bardet E, Pignon T, Rives M, Sire C, Bourhis J. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. Oral Oncol. 2017 Aug;71:61-66.

Christiaens M, Collette S, Overgaard J, Gregoire V, Kazmierska J, Castadot P, Giralt J, Grant W, Tomsej M, Bar-Deroma R, Monti AF, Hurkmans CW, Weber DC. Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure. Radiother Oncol. 2017 Jun;123(3):424-430.

Hsu MJ, Prigent J, Dollet PE, Ravau J, Larbanoix L, Van Simaeys G, Bol A, Grégoire V, Goldman S, Deblandre G, Najimi M, Sokal EM, Lombard CA. Long-Term In Vivo Monitoring of Adult-Derived Human Liver Stem/Progenitor Cells by Bioluminescence Imaging, Positron Emission Tomography, and Contrast-Enhanced Computed Tomography. Stem Cells Dev. 2017 Jul 1;26(13):986-1002.

Differding S, Sterpin E, Hermand N, Vanstraelen B, Nuyts S, de Patoul N, Denis JM, Lee JA, Grégoire V.Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc. Radiat Oncol. 2017 Mar 23;12(1):59.

Singer S, Jordan S, Locati LD, Pinto M, Tomaszewska IM, Araújo C, Hammerlid E, Vidhubala E, Husson O, Kiyota N, Brannan C, Salem D, Gamper EM, Arraras JI, Ioannidis G, Andry G, Inhestern J, Grégoire V, Licitra L; EORTC Quality of Life Group, the EORTC Head and Neck Cancer Group, and the EORTC Endocrine Task Force. The EORTC module for quality of life in patients with thyroid cancer: phase III. Endocr Relat Cancer. 2017 Apr;24(4):197-207.

Hatt M, Lee JA, Schmidtlein CR, Naqa IE, Caldwell C, De Bernardi E, Lu W, Das S, Geets X, Gregoire V, Jeraj R, MacManus MP, Mawlawi OR, Nestle U, Pugachev AB, Schöder H, Shepherd T, Spezi E, Visvikis D, Zaidi H, Kirov AS. Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211. Med Phys. 2017 Jun;44(6):e1-e42.

Van Hée VF, Labar D, Dehon G, Grasso D, Grégoire V, Muccioli GG, Frédérick R, Sonveaux PRadiosynthesis and validation of (±)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors.Oncotarget. 2017 Apr 11;8(15):24415-24428.

Classe M, Malouf GG, Su X, Yao H, Thompson EJ, Doss DJ, Grégoire V, Lenobin J, Fantoni JC, Sudour-Bonnange H, Khayat D, Aubert S, Tannir NM, Leroy X. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas. Histopathology. 2017 Jun;70(7):1089-1097.

Lapère C, Cortot AB, Grégoire V, Cockenpot V, Tulasne D, Copin MC. Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas. Am J Surg Pathol. 2017 Mar;41(3):414-422

Pasquier D, Nickers P, Peiffert D, Maingon P, Pommier P, Lacornerie T, Martinage G, Tresch E, Lartigau E.Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO). PLoS One. 2017 Nov 30;12(11):e0187794.

  1. M, Durand C, Sartelet H, Piolat C, Bourgeois E, Pommier P, Hameury F, Dieterich K, Vidaud D, Perret C. [Type 1 neurofibromatosis: Onset of two tumors before the age of 5years]. Arch Pediatr. 2017 Oct;24(10):986-990.

Bibault JE, Dussart S, Pommier P, Morelle M, Huguet M, Boisselier P, Coche-Dequeant B, Alfonsi M, Bardet E, Rives M, Calugaru V, Chajon E, Noel G, Mecellem H, Servagi Vernat S, Perrier L, Giraud P. Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted Analysis. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):929-937.

Bourmaud A, Anota A, Moncharmont C, Tinquaut F, Oriol M, Trillet-Lenoir V, Bajard A, Parnalland S, Rotonda C, Bonnetain F, Pérol D, Chauvin F. Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study. Br J Cancer. 2017 Mar 28;116(7):849-858.

Moncharmont C, Vallard A, Guy JB, Prades JM, Rancoule C, Magné N. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2017 May;134(3):165-169.

Bernichon E, Vallard A, Wang Q, Attignon V, Pissaloux D, Bachelot T, Heudel PE, Ray-Coquard I, Bonnet E, de la Fouchardière A, Faure C, Chopin N, Beurrier F, Racadot S, Sunyach MP, Rancoule C, Perol D, Corset V, Agrapart V, Tinquaut F, Blay JY, Magné N, Trédan O. Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol. Ann Oncol. 2017 Nov 1;28(11):2773-2779.

Pougnet I, Jaegle E, Garcia R, Tessier F, Faivre JC, Louvel G, Gross E, Gonzague L, Benchalal M, Ducteil A, Supiot S, Autret D, Clavier JB, Mirabel X, Bellière A, Wdowczyk D, Heymann S, Barillot I, de La Lande B, Passerat V, Sunyach MP, Lipinski F, Thibouw D, Guichard F, Chauvet B, Thariat J, Arnaud A. [Spinal stereotactic body radiotherapy: French assessment in 2016]. Cancer Radiother. 2017 Jun;21(4):276-285.

Savina M, Le Cesne A, Blay JY, Ray-Coquard I, Mir O, Toulmonde M, Cousin S, Terrier P, Ranchere-Vince D, Meeus P, Stoeckle E, Honoré C, Sargos P, Sunyach MP, Le Péchoux C, Giraud A, Bellera C, Le Loarer F, Italiano A. Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study. BMC Med. 2017 Apr 10;15(1):78.

Demoor-Goldschmidt C, Supiot S, Oberlin O, Helfre S, Vigneron C, Brillaud-Meflah V, Bernier V, Laprie A, Ducassou A, Claude L, Mahé MA, de Vathaire F. Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort study. Radiother Oncol. 2017 Aug;124(2):200-203.

Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Muracciole X, Coche-Dequeant B, Alapetite C, Bernier V, Claude L, Supiot S, Huchet A, Kerr C, le Prisé E, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE). Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma. Radiother Oncol. 2017 Mar;122(3):362-367.

Biau J, Miroir J, Millardet C, Saroul N, Pham-Dang N, Racadot S, Huguet F, Kwiatkowski F, Pereira B, Bourhis J, Lapeyre M. [Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)]. Cancer Radiother. 2017 Oct;21(6-7):527-532.

Aubé C, Oberti F, Lonjon J, Pageaux G, Seror O, N'Kontchou G, Rode A, Radenne S, Cassinotto C, Vergniol J, Bricault I, Leroy V, Ronot M, Castera L, Michalak S, Esvan M, Vilgrain V; CHIC Group. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice. Liver Int. 2017 Oct;37(10):1515-1525.

Moreau A, Giraudet AL, Kryza D, Borson-Chazot F, Bournaud C, Mognetti T, Lifante JC, Combemale P,Giammarile F, Houzard C. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas. Nucl Med Commun. 2017 Sep;38(9):771-779.

Moreau A, Giraudet AL, Kryza D, Borson-Chazot F, Bournaud-Salinas C, Mognetti T, Lifante JC, Combemale P, Giammarile F, Houzard C. FDOPA Patterns in Adrenal Glands: A Pictorial Essay. Clin Nucl Med. 2017 May;42(5):379-382.

Sarrut D, Badel JN, Halty A, Garin G, Perol D, Cassier P, Blay JY, Kryza D, Giraudet AL. 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma. EJNMMI Phys. 2017 Dec;4(1):6.

Bachelet JT, Jouan R, Prade V, Francisco C, Jaby P, Gleizal A. Place of 3D printing in facial epithesis. J Stomatol Oral Maxillofac Surg. 2017 Sep;118(4):224-227.

Bachelet JT, Mendes LC, Delafond C, Barba T, Gleizal A, Paulus C. Giant Hemifacial Fibrous Dysplasia Functional Treatment and Place of Pamidronate. J Craniofac Surg. 2017 May;28(3):706-708.

Boucher F, Gleizal A, Mojallal A, Bachelet JT. [Facial feminization surgery - middle and inferior thirds]. Ann Chir Plast Esthet. 2017 Apr;62(2):122-130.

Fernandes J, Bregman B, Combemale P, Amaz C, de Léotoing L, Vainchtock A, Gaudin AF. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).BMC Health Serv Res. 2017 Aug 8;17(1):542.

Fattouh K, Collet-Benzaquen D, Provensal AM, Desseigne F, Castillo C, Combemale P, de la Fouchardière A. Necrotizing Infundibular Crystalline Folliculitis (NICF) Induced by Anti-Tumoral Therapies: Report of 2 Cases.Am J Dermatopathol. 2017 Oct;39(10):764-766.

Bonigen J, Raynaud-Donzel C, Hureaux J, Kramkimel N, Blom A, Jeudy G, Breton AL, Hubiche T, Bedane C, Legoupil D, Pham-Ledard A, Charles J, Pérol M, Gérard E, Combemale P, Bonnet D, Sigal ML, Mahé E; Groupe de Recherche sur le Psoriasis and the Groupe Cancérologie Cutanée of the Société Française de Dermatologie the GEM Resopso, Apsoderm and the Groupe Français de Pneumo-Cancérologie. Anti-PD1-induced psoriasis: a study of 21 patients.J Eur Acad Dermatol Venereol. 2017 May;31(5):e254-e257.

Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers. Thyroid. 2017 Dec;27(12):1511-1522.  
2016

Jeanneau M, Gregoire V, Desplechain C, Escande F, Tica DP, Aubert S, Leroy X. ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult. Pathol Res Pract. 2016 Nov;212(11):1064-1066.

Cao-Pham TT, Tran LB, Colliez F, Joudiou N, El Bachiri S, Grégoire V, Levêque P, Gallez B, Jordan BF. Monitoring Tumor Response to Carbogen Breathing by Oxygen-Sensitive Magnetic Resonance Parameters to Predict the Outcome of Radiation Therapy: A Preclinical Study. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):149-60.

Henriques De Figueiredo B, Fortpied C, Menis J, Lefebvre JL, Barzan L, de Raucourt D, Geoffrois L, Giurgea L, Hupperets P, Leemans CR, Licitra L, Rolland F, Tesselaar M, Vermorken JB, Grégoire V; EORTC Head and Neck Cancer and Radiation Oncology Cooperative Groups. Long-term update of the 24954 EORTC phase III trial on larynx preservation. Eur J Cancer. 2016 Sep;65:109-12.

Karmani L, Levêque P, Bouzin C, Bol A, Dieu M, Walrand S, Vander Borght T, Feron O, Grégoire V, Bonifazi D, Michiels C, Lucas S, Gallez B.Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. Nucl Med Biol. 2016 Jul;43(7):415-23.

Suetens A, Konings K, Moreels M, Quintens R, Verslegers M, Soors E, Tabury K, Grégoire V, Baatout S.Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells. Front Oncol. 2016 Apr 13;6:87.

Tran LB, Bol A, Labar D, Karroum O, Mignion L, Bol V, Jordan BF, Grégoire V, Gallez B.DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation. Contrast Media Mol Imaging. 2016 Mar-Apr;11(2):115-21.

Neveu MA, Bol V, Bol A, Grégoire V, Gallez B.Impact of Oxygenation Status on 18F-FDG Uptake in Solid Tumors. Adv Exp Med Biol. 2016;876:201-207.

De Preter G, Deriemaeker C, Danhier P, Brisson L, Cao Pham TT, Grégoire V, Jordan BF, Sonveaux P, Gallez B. A Fast Hydrogen Sulfide-Releasing Donor Increases the Tumor Response to Radiotherapy. Mol Cancer Ther. 2016 Jan;15(1):154-61.

Polet F, Corbet C, Pinto A, Rubio LI, Martherus R, Bol V, Drozak X, Grégoire V, Riant O, Feron O. Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth.Oncotarget. 2016 Jan 12;7(2):1765-76.

Mignion L, Danhier P, Magat J, Porporato PE, Masquelier J, Gregoire V, Muccioli GG, Sonveaux P, Gallez B, Jordan BF. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism. Int J Cancer. 2016 ;138(8):2043-9.

Bouzin C, Saini ML, Khaing KK, Ambroise J, Marbaix E, Grégoire V, Bol V. Digital pathology: elementary, rapid and reliable automated image analysis. Histopathology. 2016 May;68(6):888-96.

Differding S, Sterpin E, Janssens G, Hanin FX, Lee JA, Grégoire V. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors. Acta Oncol. 2016;55(2):217-25.

Pommier P, Chabaud S, Lagrange JL, Richaud P, Le Prise E, Wagner JP, Azria D, Beckendorf V, Suchaud JP, Bernier V, Perol D, Carrie C. Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study. Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769.

Pichon B, Campion L, Delpon G, Thillays F, Carrie C, Cellier P, Pommier P, Laude C, Mervoyer A, Hamidou H, Mahé MA, Supiot S. High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study. Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):840-847.

Bibault JE, Morelle M, Perrier L, Pommier P, Boisselier P, Coche-Dequéant B, Gallocher O, Alfonsi M, Bardet É, Rives M, Calugaru V, Chajon E, Noël G, Mecellem H, Pérol D, Dussart S, Giraud P. Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancer. Cancer Radiother. 2016 Jul;20(5):357-61

Perrier L, Morelle M, Pommier P, Boisselier P, Coche-Dequeant B, Gallocher O, Alfonsi M, Bardet E, Rives M, Calugaru V, Chajon E, Noel G, Mecellem H, Pérol D, Dussart S, Giraud P. Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):654-62.

Fargier-Voiron M, Presles B, Pommier P, Munoz A, Rit S, Sarrut D, Biston MC. Evaluation of a new transperineal ultrasound probe for inter-fraction image-guidance for definitive and post-operative prostate cancer radiotherapy. Phys Med. 2016 Mar;32(3):499-505.

Moncharmont C, Guy JB, Wozny AS, Gilormini M, Battiston-Montagne P, Ardail D, Beuve M, Alphonse G, Simoëns X, Rancoule C, Rodriguez-Lafrasse C, Magné N. Carbonion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC). Oncotarget. 2016 Jul 26;7(30):47738-47749.

Vallard A, Guy JB, Mengue Ndong S, Vial N, Rivoirard R, Auberdiac P, Méry B, Langrand-Escure J, Espenel S, Moncharmont C, Ben Mrad M, Diao P, Goyet D, Magné N. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry. Head Neck. 2016 Jul;38(7):1028-34.

Rivoirard R, Chargari C, Kullab S, Trone JC, Langrand-Escure J, Moriceau G, Guy JB, Annede P, Méry B, Moncharmont C, Falk AT, Vedrine L, Merrouche Y, Fournel P, Magné N. Chemotherapy Regimen in Nonagenarian Cancer Patients: A Bi-Institutional Experience. Chemotherapy. 2016;61(2):65-71.

Moncharmont C, Vallard A, Mengue Ndong S, Guy JB, Saget C, Méry B, Langrand-Escure J, de Laroche G, Goyet D, Prades JM, Fournel P, Magné N. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment. Acta Otolaryngol. 2016;136(2):181-8.

Frappaz D, Sunyach MP, Le Rhun E, Blonski M, Laurence V, Bonneville Levard A, Loiseau H, Meyronnet D, Callies A, Laigle-Donadey F, Faure Conter C; au nom de l’ANOCEF, GO-AJA, de la SFCE. [Adolescent and Young Adults (AYAS) brain tumor national Web conference. On behalf of ANOCEF, GO-AJA and SFCE societies]. Bull Cancer. 2016 Dec;103(12):1050-1056.

Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation? J Neurooncol. 2016 Oct;130(1):181-192. Epub 2016 Aug 8. PubMed PMID: 27502603.

Le Péchoux C, Moureau-Zabotto L, Llacer C, Ducassou A, Sargos P, Sunyach MP, Thariat J. [Radiotherapy of adult soft tissue sarcoma]. Cancer Radiother. 2016 Sep;20 Suppl:S235-43.

Atallah V, Honore C, Orbach D, Helfre S, Ducassou A, Thomas L, Levitchi MB, Mervoyer A, Naji S, Dupin C, Bosco-Levy PJ, Philippe-Chomette P, Kantor G, Henriques de Figueiredo B, Sunyach MP, Sargos P. Role of Adjuvant Radiation Therapy After Surgery for Abdominal Desmoplastic Small Round Cell Tumors. Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1244-53.

Fourquet J, Sunyach MP, Vilotte F, Le Péchoux C, Ranchère-Vince D, Bonvalot S, Coindre JM, Terrier P, Meeus P, Helfre S, Martin E, Vogin G, Biau J, Kao W, Noel G, Ducassou A, Llacer-Moscardo C, Stoeckle E, Penel N, Sargos P. Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group. Radiother Oncol. 2016 Jul;120(1):156-62.

Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A. Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation. Eur Radiol. 2016 Nov;26(11):4194-4203. Epub 2016 Feb 2. PubMed PMID: 26843012.

Seror E, Donadieu J, Pacquement H, Abbou S, Lambilliotte A, Schell M, Curtillet C, Gandemer V, Pasquet M, Aladjidi N, Lutz P, Schmitt C, Deville A, Minckes O, Vanier JP, Armari-Alla C, Thomas C, Gorde-Grosjean S, Millot F, Blouin P, Garnier N, Coze C, Devoldere C, Reguerre Y, Helfre S, Claude L, Clavel J, Oberlin O, Landman-Parker J, Leblanc T.Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines. Pediatr Hematol Oncol. 2016 Oct - Nov;33(7-8):423-437.

Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE). Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study. Br J Radiol. 2016 Oct;89(1066):20160537.

Demoor-Goldschmidt C, Claude L, Carrie C, Bolle S, Helfre S, Alapetite C, Jouin A, Padovani L, Ducassou A, Vigneron C, Le Prisé É, Huchet A, Stefan D, Kerr C, Nguyen TD, Truc G, Chapet S, Bondiau PY, Coche B, Muracciole X, Laprie A, Noël G, Leseur J, Habrand JL, Potet H, Ruffier A, Supiot S, Mahé MA, Bernier V. [French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)]. Cancer Radiother. 2016 Jul;20(5):395-9.

Gokce-Samar Z, Beuriat PA, Faure-Conter C, Carrie C, Chabaud S, Claude L, Di Rocco F, Mottolese C, Szathmari A, Chabert C, Frappaz D. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst. 2016 32(8):1415-23

Demoor-Goldschmidt C, Supiot S, Claude L, Carrie C, Mazeron R, Helfré S, Alapetite C, Jouin A, Coche B, Padovani L, Muracciole X, Bernier V, Vigneron C, Noël G, Leseur J, Le Prisé É, Stefan D, Habrand JL, Kerr C, Bondiau PY, Ruffier A, Chapet S, Mahé MA.[French experience in paediatric total body irradiation: A study from the radiotherapy committee of the Société française des cancers de l'enfant (SFCE)]. Cancer Radiother. 2016 Jun;20(4):304-7.

Foulon S, Brennan B, Gaspar N, Dirksen U, Jeys L, Cassoni A, Claude L, Seddon B, Marec-Berard P, Whelan J, Paulussen M, Streitbuerger A, Oberlin O, Juergens H, Grimer R, Le Deley MC. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. Eur J Cancer. 2016 Jul;61:128-36.

Boisselier P, Racadot S, Thariat J, Graff P, Pointreau Y. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus]. Cancer Radiother. 2016 Oct;20(6-7):459-66.

Pointreau Y, Lizée T, Bensadoun RJ, Boisselier P, Racadot S, Thariat J, Graff P. [Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].Cancer Radiother. 2016 Oct;20(6-7):445-51.

Tétreau R, Beji H, Henry L, Valette PJ, Pilleul F Arterial splanchnic aneurysms: Presentation, treatment and outcome in 112 patients. Diagn Interv Imaging. 2016 Jan;97(1):81-90

Képénékian L, Mognetti T, Lifante JC, Giraudet AL, Houzard C, Pinson S, Borson-Chazot F, Combemale P. Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1. Eur J Endocrinol. 2016 Oct;175(4):335-44.

de la Fouchardiere C, Oussaid N, Derbel O, Decaussin-Petrucci M, Fondrevelle ME, Wang Q, Bringuier PP, Bournaud-Salinas C, Peix JL, Lifante JC, Giraudet AL, Lopez J, Borson-Chazot F. Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study. Target Oncol. 2016 Feb;11(1):71-82.

Bachelet JT, Souchere B, Mojallal A, Gleizal A, Boucher F. [Facial feminization surgery - upper third]. Ann Chir Plast Esthet. 2016 Dec;61(6):877-881

Dummer R, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, Herd RM, Kaatz M, Loquai C, Stratigos AJ, Schulze HJ, Plummer R, Gogov S, Pallaud C, Yi T, Mone M, Chang AL, Cornélis F, Kudchadkar R, Trefzer U, Lear JT, Sellami D, Migden MR. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. J Am Acad Dermatol. 2016 Jul;75(1):113-125.e5.

Combemale P, Hetu J, Aubriot-Lorton MH, Jeudy G, Chassagne-Clément C, Castillo C, Provensal AM, Coquard IR, Dalac-Rat S. Cutaneous lesions in sporadic angiosarcomas of the breast: a misleading presentation. Eur J Dermatol. 2016 ;26(3):287-9.

Jalenques I, Rondepierre F, Massoubre C, Haffen E, Grand JP, Labeille B, Perrot JL, Aubin F, Skowron F, Mulliez A, D'Incan M; Lupus Group. High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case-control study. Br J Dermatol. 2016 May;174(5):1051-60.

Petronio M, Pinson S, Walter T, Joly MO, Hervieu V, Forestier J, Saurin JC. Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC, and PTEN genes. United European Gastroenterol J. 2016 Apr;4(2):305-13. 

2015

Van Gestel D, Van den Weyngaert D, De Kerf G, De Ost B, Vanderveken O, Van Laer C, Specenier P, Geussens Y, Wouters K, Meulemans E, Cheung KJ, Grégoire V, Vermorken JB. Helical tomotherapy in head and neck cancer: a European single-center experience. Oncologist. 2015 Mar;20(3):279-90.

Tran LB, Bol A, Labar D, Cao-Pham TT, Jordan B, Grégoire V, Gallez B. Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study. Radiother Oncol. 2015 Feb;114(2):189-94.

Servagi-Vernat S, Differding S, Sterpin E, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study. Acta Oncol. 2015 Jul;54(7):1008-16.

Suetens A, Moreels M, Quintens R, Soors E, Buset J, Chiriotti S, Tabury K, Gregoire V, Baatout S.Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation. J Radiat Res. 2015 Jan;56(1):11-21.

Bol V, Bol A, Bouzin C, Labar D, Lee JA, Janssens G, Porporato PE, Sonveaux P, Feron O, Grégoire V.Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation. Acta Oncol. 2015 Feb;54(2):266-74.

Sterpin E, Differding S, Janssens G, Geets X, Grégoire V, Lee JA. Generation of prescriptions robust against geometric uncertainties in dose painting by numbers. Acta Oncol. 2015 Feb;54(2):253-60. doi: 10.3109/0284186X.2014.930171.

Le Rhun E, Chamberlain MC, Zairi F, Delmaire C, Idbaih A, Renaud F, Maurage CA, Grégoire V. Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients.CNS Oncol. 2015;4(6):381-6.

Brouwer CL, Steenbakkers RJ, Bourhis J, Budach W, Grau C, Grégoire V, van Herk M, Lee A, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Rosenthal DI, Sijtsema NM, Langendijk JA. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015 Oct;117(1):83-90.

Leclerc M, Lartigau E, Lacornerie T, Daisne JF, Kramar A, Grégoire V. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. Radiother Oncol. 2015 Jul;116(1):87-93.

Differding S, Sterpin E, Janssens G, Hanin FX, Lee JA, Grégoire V. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors. Acta Oncol. 2016;55(2):217-25.

Neveu MA, Bol V, Bol A, Bouzin C, Grégoire V, Feron O, Jordan BF, Gallez B.The increase in tumor oxygenation under carbogen breathing induces a decrease in the uptake of [(18)F]-fluoro-deoxy-glucose.Radiother Oncol. 2015 Sep;116(3):400-3.

Lantuejoul S, Rouquette I, Blons H, Le Stang N, Ilie M, Begueret H, Grégoire V, Hofman P, Gros A, Garcia S, Monhoven N, Devouassoux-Shisheboran M, Mansuet-Lupo A, Thivolet F, Antoine M, Vignaud JM, Penault-Llorca F, Galateau-Sallé F, McLeer-Florin A. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas. Eur Respir J. 2015 Jul;46(1):207-18.

Fayette J, Molin Y, Lavergne E, Montbarbon X, Racadot S, Poupart M, Ramade A, Zrounba P, Ceruse P, Pommier P. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma. Drug Des Devel Ther. 2015 Nov 26;9:6203-10.

Fargier-Voiron M, Presles B, Pommier P, Munoz A, Rit S, Sarrut D, Biston MC. Ultrasound versus Cone-beam CT image-guided radiotherapy for prostate and post-prostatectomy pretreatment localization. Phys Med. 2015 Dec;31(8):997-1004.

De Bari B, Lestrade L, Pommier P, Maddalo M, Buglione M, Magrini SM, Carrie C. Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients. Cancer Invest. 2015 Apr;33(4):114-20

Maignan M, Richard A, Debaty G, Pommier P, Viglino D, Loizzo F, Timsit JF, Hanna J, Carpentier F, Danel V. Intentional drug poisoning care in a physician-manned emergency medical service. Prehosp Emerg Care. 2015 Apr-Jun;19(2):224-31.

Malclès A, Kivelä T, Svetlosakova Z, Jean-Louis B, Nguyen AM, Sallit R, Négrier S, Pommier P, Rivoire M, Chauvel P, Mammar H, Devouassoux-Shisheboran M, Kodjikian L, Denis P, Grange JD. Small metastasizing choroidal melanomas. Acta Ophthalmol. 2015 Mar;93(2):e160-6.

Méry B, Falk AT, Assouline A, Trone JC, Guy JB, Rivoirard R, Auberdiac P, Escure JL, Moncharmont C, Moriceau G, Almokhles H, de Laroche G, Pacaut C, Guillot A, Chargari C, Magné N. Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored? Int Urol Nephrol. 2015 Jul;47(7):1129-34.

Trone JC, Mengue Ndong S, Falk AT, Annede P, Rivoirard R, Guy JB, Langrand-Escure J, Méry B, Espenel S, Ben Mrad M, Vallard A, Auberdiac P, Moncharmont C, Assouline A, de Laroche G, Chargari C, Magné N. Skin cancers in nonagenarian patients: special focus on radiotherapy. Clin Oncol (R Coll Radiol). 2015 Jun;27(6):371.

Rivoirard R, Moncharmont C, Assouline A, Auberdiac P, Mery B, Falk AT, Annède P, Trone JC, Guy JB, Vial N, Fournel P, Merrouche Y, Chargari C, Magné N. Radiotherapy for head and neck cancer in nonagenarian patients: a possible cornerstone? Eur Arch Otorhinolaryngol. 2015 Mar;272(3):719-25.

Lévy C, Allouache D, Lacroix J, Dugué AE, Supiot S, Campone M, Mahe M, Kichou S, Leheurteur M, Hanzen C, Dieras V, Kirova Y, Campana F, Le Rhun E, Gras L, Bachelot T, Sunyach MP, Hrab I, Geffrelot J, Gunzer K, Constans JM, Grellard JM, Clarisse B, Paoletti X. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours. Ann Oncol. 2015 Nov;26(11):2359.

Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, Collette L, Fourquet A, Maingon P, Valli M, De Winter K, Marnitz S, Barillot I, Scandolaro L, Vonk E, Rodenhuis C, Marsiglia H, Weidner N, van Tienhoven G, Glanzmann C, Kuten A, Arriagada R, Bartelink H, Van den Bogaert W; EORTC Radiation Oncology and Breast Cancer Groups. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med. 2015 Jul 23;373(4):317-27.

Falk AT, Moureau-Zabotto L, Ouali M, Penel N, Italiano A, Bay JO, Olivier T, Sunyach MP, Boudou-Roquette P, Salas S, Le Maignan C, Ducassou A, Isambert N, Kalbacher E, Pan C, Saada E, Bertucci F, Thyss A, Thariat J; Groupe Sarcome Francais-Groupe D'etude Des Tumeurs Osseuses. Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group. Clin Oncol (R Coll Radiol). 2015 Jan;27(1):48-55.

Ducassou A, Gambart M, Munzer C, Padovani L, Carrie C, Haas-Kogan D, Bernier-Chastagner V, Demoor C, Claude L, Helfre S, Bolle S, Leseur J, Huchet A, Rubie H, Valteau-Couanet D, Schleiermacher G, Coze C, Defachelles AS, Marabelle A, Ducassou S, Devalck C, Gandemer V, Munzer M, Laprie A; Neuroblastoma study group and radiotherapy group of the French Society of Children with Cancer (SFCE). Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.Strahlenther Onkol. 2015 Jul;191(7):604-12.

Péron J, Bylicki O, Laude C, Martel-Lafay I, Carrie C, Racadot S. Nonoperative management of squamous-cell carcinoma of the rectum. Dis Colon Rectum. 2015 Jan;58(1):60-4.

Richioud B, Louazon T, Beji H, Bertrand A, Roux P, Kalenderian AC, Cuinet M, Pilleul F, Marec-Bérard P De novo radiologic placement of button gastrostomy: a feasibility study in children with cancer. Pediatr Radiol. 2015 Dec;45(13):1957-63.

Beji H, De La Fouchardière C, Desseigne F, Thiesse P, Richioud B, Pilleul F. Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatment. Diagn Interv Imaging. 2015 Apr;96(4):383-6.

Beji H, Zrounba P, Blay JY, Richioud B, Pilleul F. Hemorrhage due to radiation-induced sarcoma of the mandible: treatment with percutaneous cryotherapy. Diagn Interv Imaging. 2015 Apr;96(4):407-9.

Leporq B, Saint-Jalmes H, Rabrait C, Pilleul F, Guillaud O, Dumortier J, Scoazec JY, Beuf O. Optimization of intra-voxel incoherent motion imaging at 3.0 Tesla for fast liver examination. J Magn Reson Imaging. 2015 May;41(5):1209-17.

Bachelet JT, Bourlet J, Château J, Jacquemart M, Dufour C, Mojallal A, Gleizal A.Costal Grafting in Mandibular Reconstruction. Plast Reconstr Surg Glob Open. 2015 Dec 9;3(11):e565.

Bourlet J, Bachelet JT, Beziat JL, Gleizal A. [Upper eyelid congenital coloboma, aethiology pathogenesis and management]. Rev Stomatol Chir Maxillofac Chir Orale. 2015 Jun;116(3):147-52.

Ernoult C, Bouletreau P, Meyer C, Aubry S, Breton P, Bachelet JT. [Reconstruction assisted by 3D printing in maxillofacial surgery]. Rev Stomatol Chir Maxillofac Chir Orale. 2015 Apr;116(2):95-102.

Brahmi M, Thiesse P, Ranchere D, Mognetti T, Pinson S, Renard C, Decouvelaere AV, Blay JY, Combemale P.Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. PLoS One. 2015 Oct 7;10(10):e0138386.

Migden MR, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, Herd RM, Kudchadkar R, Trefzer U, Gogov S, Pallaud C, Yi T, Mone M, Kaatz M, Loquai C, Stratigos AJ, Schulze HJ, Plummer R, Chang AL, Cornélis F, Lear JT, Sellami D, Dummer R. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015 Jun;16(6):716-28.

de la Fouchardière A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, Bonadona V, Soufir N, Bressac-de Paillerets B. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet. 2015 Sep;88(3):273-7.

Houang M, Castillo C, La Marca S, Combemale P, Wang Q, Paindavoine S, Pissaloux D, de la Fouchardiere A. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule. Am J Dermatopathol. 2015 Apr;37(4):299-304.

Moussata D, Senouci L, Berger F, Scoazec JY, Pinson S, Walter T, Lombard-Bohas C, Saurin JC. Familial adenomatous polyposis and pancreatic cancer. Pancreas. 2015 Apr;44(3):512-3. 
Imbard A, Pasmant E, Sabbagh A, Luscan A, Soares M, Goussard P, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanne-Chantelot C, Vidaud D, Wolkenstein P; members of the NF France Network, Parfait B. NF1 single and multi-exons copy number variations in neurofibromatosis type 1. J Hum Genet. 2015 Apr;60(4):221-4. 
Grandval P, Fabre AJ, Gaildrat P, Baert-Desurmont S, Blayau M, Buisine MP, Coulet F, Maugard C, Pinson S, Remenieras A, Rouleau E, Uhrhammer N, Beroud C, Olschwang S. Genomic variations integrated database for MUTYH-associated adenomatous polyposis. J Med Genet. 2015 Jan;52(1):25-7. 
2014

Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Lengele B. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014 Jan;110(1):172-81.

Suárez C, Rodrigo JP, Mendenhall WM, Hamoir M, Silver CE, Grégoire V, Strojan P, Neumann HP, Obholzer R, Offergeld C, Langendijk JA, Rinaldo A, Ferlito A.Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy. Eur Arch Otorhinolaryngol. 2014 Jan;271(1):23-34.

Maingon P, Govaerts AS, Rivera S, Vens C, Shash E, Grégoire V.New challenge of developing combined radio-drug therapy. Chin Clin Oncol. 2014 Jun;3(2):18.

Van Gestel D, Van den Weyngaert D, De Kerf G, De Ost B, Vanderveken O, Van Laer C, Specenier P, Geussens Y, Wouters K, Meulemans E, Cheung KJ, Grégoire V, Vermorken JB.Helical tomotherapy in head and neck cancer: a European single-center experience. Oncologist. 2015 Mar;20(3):279-90.

Tran LB, Bol A, Labar D, Cao-Pham TT, Jordan B, Grégoire V, Gallez B Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study. Radiother Oncol. 2015 Feb;114(2):189-94.

Differding S, Hanin FX, Grégoire V. PET imaging biomarkers in head and neck cancer.Eur J Nucl Med Mol Imaging. 2015 42(4):613-22.

Servagi-Vernat S, Differding S, Sterpin E, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study. Acta Oncol. 2015 Jul;54(7):1008-16.

Tran LB, Bol A, Labar D, Karroum O, Bol V, Jordan B, Grégoire V, Gallez B. Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy. Radiother Oncol. 2014 113(2):204-9.

Suetens A, Moreels M, Quintens R, Soors E, Buset J, Chiriotti S, Tabury K, Gregoire V, Baatout S. Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation. J Radiat Res. 2015 Jan;56(1):11-21

Bol V, Bol A, Bouzin C, Labar D, Lee JA, Janssens G, Porporato PE, Sonveaux P, Feron O, Grégoire VReprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation. Acta Oncol. 2015 Feb;54(2):266-74.

Sterpin E, Differding S, Janssens G, Geets X, Grégoire V, Lee JA. Generation of prescriptions robust against geometric uncertainties in dose painting by numbers. Acta Oncol. 2015 Feb;54(2):253-60.

Ivashkin P, Lemonnier G, Cousin J, Grégoire V, Labar D, Jubault P, Pannecoucke X [(18) F]CuCF3 : a [(18) F]trifluoromethylating agent for arylboronic acids and aryl iodides. Chemistry. 2014 Jul 28;20(31):9514-8.

Weber DC, Hurkmans CW, Melidis C, Budach W, Langendijk JH, Peters LJ, Grégoire V, Maingon P, Combescure C.Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer. Radiother Oncol. 2014 Jun;111(3):393-9.

Servagi-Vernat S, Differding S, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V. A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1544-52

Karmani L, Bouchat V, Bouzin C, Levêque P, Labar D, Bol A, Deumer G, Marega R, Bonifazi D, Haufroid V, Michiels C, Grégoire V, Feron O, Lucas S, Vander Borght T, Gallez B.(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy. Nanomedicine (Lond). 2014 Sep;9(13):1923-37.

Suetens A, Moreels M, Quintens R, Chiriotti S, Tabury K, Michaux A, Grégoire V, Baatout S Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study. Int J Oncol. 2014 Apr;44(4):1056-72.

Arens AI, Troost EG, Hoeben BA, Grootjans W, Lee JA, Grégoire V, Hatt M, Visvikis D, Bussink J, Oyen WJ, Kaanders JH, Visser EP Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome. Eur J Nucl Med Mol Imaging. 2014 May;41(5):915-24.

Presles B, Fargier-Voiron M, Biston MC, Lynch R, Munoz A, Liebgott H, Pommier P, Rit S, Sarrut D. Semiautomatic registration of 3D transabdominal ultrasound images for patient repositioning during postprostatectomy radiotherapy. Med Phys. 2014 Dec;41(12):122903.

Perrier L, Morelle M, Pommier P, Boisselier P, Lartigau E, Gallocher O, Alfonsi M, Bardet E, Rives M, Calugaru V, Chajon E, Noel G, Mecellem H, Pérol D, Dussart S, Giraud P. A Cost-Analysis of Complex Radiotherapy in Patients with Head and Neck Cancer Results from the Art-Orl Study. Value Health. 2014 Nov;17(7):A624.

Céruse P, Cosmidis A, Belot A, Rabilloud M, Fuchsmann C, Poupart M, Ramade A, Tartas S, Favrel V, Pommier P, Zrounba P, Fayette J. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. Anticancer Drugs. 2014 Sep;25(8):970-5.

Servagi-Vernat S, Giraud P, Fenoglietto P, Azria D, Lisbona A, de La Rochefordière A, Zefkili S, Fau P, Resbeut M, Huger S, Peiffert D, Meyer P, Noël G, Mazurier J, Latorzeff I, Biston MC, Pommier P, Ledu D, Garcia R, Chauvet B, Dudouet P, Belhomme S, Kantor G, Mahé MA. [Impact of dynamic IMRT and tomotherapy in pelvic cancers: a prospective dosimetric study with 51 patients]. Cancer Radiother. 2014 Mar;18(2):111-8.

Fargier-Voiron M, Presles B, Pommier P, Rit S, Munoz A, Liebgott H, Sarrut D, Biston MC. Impact of probe pressure variability on prostate localization for ultrasound-based image-guided radiotherapy. Radiother Oncol. 2014 Apr;111(1):132-7.

Lestrade L, De Bari B, Pommier P, Montbarbon X, Lavergne E, Ardiet JM, Carrie C. Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series. Strahlenther Onkol. 2014 Jun;190(6):546-54.

Vernat SS, Ali D, Messina C, Pommier P, Dussart S, Puyraveau M, Viard R, Lacornerie T, Lisbona A, Fenoglietto P, Mazurier J, Garcia R, Hangard G, Zefkili S, Makovicka L, Giraud P. Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: a comparative and prospective multicenter planning study. Cancer Invest. 2014 Jun;32(5):159-67.

Vasson MP, Talvas J, Perche O, Dillies AF, Bachmann P, Pezet D, Achim AC, Pommier P, Racadot S, Weber A, Ramdani M, Kwiatkowski F, Bouteloup C. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial. Clin Nutr. 2014 Apr;33(2):204-10.

Chargari C, Guy JB, Falk AT, Schouver ED, Trone JC, Moncharmont C, Védrine L, Magné N. Cardiotoxicity research in breast cancer patients: past and future. Am J Cardiol. 2014 Apr 15;113(8):1447-8.

Lévy C, Allouache D, Lacroix J, Dugué AE, Supiot S, Campone M, Mahe M, Kichou S, Leheurteur M, Hanzen C, Dieras V, Kirova Y, Campana F, Le Rhun E, Gras L, Bachelot T, Sunyach MP, Hrab I, Geffrelot J, Gunzer K, Constans JM, Grellard JM, Clarisse B, Paoletti X. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours. Ann Oncol. 2014 Dec;25(12):2351-6.

Cassier PA, Kantor G, Bonvalot S, Lavergne E, Stoeckle E, Le Péchoux C, Meeus P, Sunyach MP, Vaz G, Coindre JM, Linassier C, Labib A, Delcambre C, Bay JO, Leyvraz S, Dubergé T, Lagrange JL, Duret A, Blay JY. Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study. Ann Oncol. 2014 Sep;25(9):1854-60.

Badaoui N, Meyronet D, Cartalat-Carel S, Guyotat J, Jouanneau E, d'Hombres A, Sunyach MP, Jouvet A, Louis-Tisserand G, Archinet A, Frappaz D, Bauchet L, Honnorat J, Ducray F. Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France. Rev Neurol (Paris). 2014Mar;170(3):222-7.

Fayet Y, Chasles V, Ducimetière F, Collard O, Berger C, Meeus P, Ranchère-Vince D, Thiesse P, Sunyach MP, Marec-Bérard P, Poncet L, Cousin P, Blay JY, Ray-Coquard I. [To answer rare cancer issues. Geographical analysis of EMS sarcoma cohort in the Rhône-Alpes region]. Bull Cancer. 2014 Feb;101(2):127-36.

Alcorn SR, Chen MJ, Claude L, Dieckmann K, Ermoian RP, Ford EC, Malet C, MacDonald SM, Nechesnyuk AV, Nilsson K, Villar RC, Winey BA, Tryggestad EJ, Terezakis SA. Practice patterns of photon and proton pediatric image guided radiation treatment: results from an International Pediatric Research consortium. Pract Radiat Oncol. 2014 Sep-Oct;4(5):336-341

Sarrut D, Rit S, Claude L, Pinho R, Pitson G, Bouilhol G, Lynch R. Learning directional relative positions between mediastinal lymph node stations and organs. Med Phys. 2014 Jun;41(6):061905

Hamel B, Guillaud O, Roman S, Vallin M, Pilleul F, Valette PJ, Henry L, Guibal A, Mion F, Dumortier J. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney. Dig Liver Dis. 2014 Nov;46(11):1001-7.

Lablanche S, Borot S, Thaunat O, Bayle F, Badet L, Morelon E, Thivolet C, Wojtusciszyn A, Frimat L, Kessler L, Penfornis A, Brault C, Colin C, Bosco D, Berney T, Benhamou PY; GRAGIL Network. Impact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network. Transplantation. 2014 Aug 27;98(4):475-82.

Massicotte MH, Brassard M, Claude-Desroches M, Borget I, Bonichon F, Giraudet AL, Do Cao C, Chougnet CN, Leboulleux S, Baudin E, Schlumberger M, de la Fouchardière C. Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network. Eur J Endocrinol. 2014 Mar 8;170(4):575-82

Bachelet JT, Buiret G, Chevallier M, Bergerot JF, Ory L, Gleizal A. [Conidiobolus coronatus infections revealed by a facial tumor]. Rev Stomatol Chir Maxillofac Chir Orale. 2014 Apr;115(2):114-7.

Lubrano V, Derrey S, Truc G, Mirabel X, Thariat J, Cupissol D, Sassolas B, Combemale P, Modiano P, Bedane C, Dygai-Cochet I, Lamant L, Mourrégot A, Rougé Bugat MÈ, Siegrist S, Tiffet O, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT; Institut nationalducancer[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]. Neurochirurgie. 2014 Dec;60(6):269-75

Lion-François L, Gueyffier F, Mercier C, Gérard D, Herbillon V, Kemlin I, Rodriguez D, Ginhoux T, Peyric E, Coutinho V, Bréant V, des Portes V, Pinson S, Combemale P, Kassaï B; Réseau NF1 Rhône Alpes Auvergne-France. The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial. Orphanet J Rare Dis. 2014 Sep 10;9:142.

Combemale P, Valeyrie-Allanore L, Giammarile F, Pinson S, Guillot B, Goulart DM, Wolkenstein P, Blay JY, Mognetti T. Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1. PLoS One. 2014 Feb 6;9(2):e85954.

Leccia MT, Planchamp F, Sassolas B, Combemale P, Modiano P, Bedane C, Cupissol D, Derrey S, Dygai-Cochet I, Lamant L, Lubrano V, Mirabel X, Mourrégot A, Rougé Bugat ME, Siegrist S, Thariat J, Tiffet O, Truc G, Verdoni L, Mazeau-Woynar V[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute]. Ann Dermatol Venereol. 2014 Feb;141(2):111-21.

Drouet A, Le Moigne F, Salamé D, Quesnel L, Motolese C, des Portes V, Guilloton L, Pinson S. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression]. Arch Pediatr. 2014 Nov;21(11):1233-40.
Pôle d'Unité « ENVIRONNEMENT ET ESPACE » 

2020

Delrieu L, Pialoux V, Pérol O, Morelle M, Martin A, Friedenreich C, Febvey-Combes O, Pérol D, Belladame E, Clémençon M, Roitmann E, Dufresne A, Bachelot T, Heudel PE, Touillaud M, Trédan O, Fervers B. Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study. JMIR Mhealth Uhealth. 2020 Jan 28;8(1):e12306.

Perrier L, Foucaut AM, Morelle M, Touillaud M, Kempf-Lépine AS, Heinz D, Gomez F, Meyrand R, Baudinet C, Berthouze S, Reynes E, Carretier J, Guillemaut S, Pérol D, Trédan O, Philip T, Bachmann P, Fervers B. Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial. Support Care Cancer. 2019 Nov 15.

Delrieu L, Vallance JK, Morelle M, Fervers B, Pialoux V, Friedenreich C, Dufresne A, Bachelot T, Heudel PE, Trédan O, Pérol O, Touillaud M. Physical activity preferences before and after participation in a 6-month physical activity intervention among women with metastatic breast cancer. Eur J Cancer Care (Engl). 2020 Jan;29(1):e13169.

2019

Foucaut AM, Morelle M, Kempf-Lépine AS, Baudinet C, Meyrand R, Guillemaut S, Metzger S, Bourne-Branchu V, Grinand E, Chabaud S, Pérol D, Carretier J, Berthouze SE, Reynes E, Perrier L, Rebattu P, Heudel PE, Bachelot T, Bachmann P, Fervers B, Trédan O, Touillaud M. Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial. Support Care Cancer. 2019 Sep;27(9):3449-3461.

Mancini FR, Praud D, Fervers B, Boutron-Ruault MC.Estimation of the dietary exposure to chemical compounds in the French E3N prospective cohort: a study protocol. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2020 Jan;37(1):39-47.

Falette N, Fervers B, Carretier J. [Cancers and environmental exposures: Between uncertainties and certainties]. Bull Cancer. 2019 Nov;106(11):975-982.

Lamort-Bouché M, Péron J, Broc G, Kochan A, Jordan C, Letrilliart L, Fervers B, Fassier JB; FASTRACS Group. Breast cancer specialists' perspective on their role in their patients' return to work: A qualitative study.Scand J Work Environ Health. 2020 Mar 1;46(2):177-187.

Béranger R, Billoir E, Nuckols JR, Blain J, Millet M, Bayle ML, Combourieu B, Philip T, Schüz J, Fervers B. Agricultural and domestic pesticides in house dust from different agricultural areas in France. Environ Sci Pollut Res Int. 2019 Jul;26(19):19632-19645.

Havet N, Penot A, Plantier M, Morelle M, Fervers B, Charbotel B. Trends in the Control Strategies for Occupational Exposure to Carcinogenic, Mutagenic, and Reprotoxic Chemicals in France (2003-2010). Ann Work Expo Health. 2019 May 21;63(5):488-504.

Ratajczak R, Crispim-Junior CF, Faure E, Fervers B, Tougne L. Automatic Land Cover Reconstruction From Historical Aerial Images: An Evaluation of Features Extraction and Classification Algorithms. IEEE Trans Image Process. 2019 Jul;28(7):3357-3371.

Amadou A, Praud D, Coudon T, Danjou AMN, Faure E, Leffondré K, Le Romancer M, Severi G, Salizzoni P, Mancini FR, Fervers B. Chronic long-term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort. Int J Cancer. 2019 Mar 9.

Coudon T, Danjou AMN, Faure E, Praud D, Severi G, Mancini FR, Salizzoni P, Fervers B. Development and performance evaluation of a GIS-based metric to assess exposure to airborne pollutant emissions from industrial sources. Environ Health. 2019 Jan 25;18(1):8.

Danjou AMN, Coudon T, Praud D, Lévêque E, Faure E, Salizzoni P, Le Romancer M, Severi G, Mancini FR, Leffondré K, Dossus L, Fervers B.Long-term airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3N prospective cohort.Environ Int. 2019 Mar;124:236-248.

Deneuve S, Charbotel B, Massardier-Pilonchéry A, Fort E, Milliet-Baude C, Pérol O, Fayette J, Zrounba P, Fervers B. Systematic screening for occupations and occupational exposures in head and neck squamous cell carcinoma patients. Eur Arch Otorhinolaryngol. 2019 Mar;276(3):857-864

Marant Micallef C, Shield KD, Vignat J, Baldi I, Charbotel B, Fervers B, Gilg Soit Ilg A, Guénel P, Olsson A, Rushton L, Hutchings SJ, Cléro E, Laurier D, Scanff P, Bray F, Straif K, Soerjomataram I. Cancers in France in 2015 attributable to occupational exposures. Int J Hyg Environ Health. 2019 Jan;222(1):22-294

Havet N, Penot A, Plantier M, Charbotel B, Morelle M, Fervers B. Inequalities in the control of the occupational exposure in France to carcinogenic, mutagenic and reprotoxic chemicals. Eur J Public Health. 2019 Feb 1;29(1):140-147.

Autier P, Doré JF. Ultraviolet radiation and cutaneous melanoma: a historical perspective. Melanoma Res. 2019 Apr 8.

Labrèche F, Guénel P, Lévi F, Doré JF, Costa G, Lasfargues G, Gronfier C; Working Group on “Assessment of the Health Risks for Professionals Exposed to Atypical Working Hours, Especially Night Work,” French Agency for Food, Environmental and Occupational Health & Safety. Night Shift Work Increases Cancer Risk of Women-Letter. Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):422.

2018

Delrieu L, Pérol O, Fervers B, Friedenreich C, Vallance J, Febvey-Combes O, Pérol D, Canada B, Roitmann E, Dufresne A, Bachelot T, Heudel PE, Trédan O, Touillaud M, Pialoux V. A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial. JMIR Res Protoc. 2018 Aug 30;7(8):e10487

Olsson A, Togawa K, Schüz J, Le Cornet C, Fervers B, Oksbjerg Dalton S, Pukkala E, Maria Feychting MF, Skakkebæk NE, Hansen J. Parental occupational exposure to solvents and heavy metals and risk of developing testicular germ cell tumors in sons (NORD-TEST Denmark). Scand J Work Environ Health. 2018 Nov 1;44(6):658-669.

Marant Micallef C, Shield KD, Baldi I, Charbotel B, Fervers B, Gilg Soit Ilg A, Guénel P, Olsson A, Rushton L, Hutchings SJ, Straif K, Soerjomataram I. Occupational exposures and cancer: a review of agents and relative risk estimates. Occup Environ Med. 2018 Aug;75(8):604-614.

Fassier JB, Lamort-Bouché M, Broc G, Guittard L, Péron J, Rouat S, Carretier J, Fervers B, Letrilliart L, Sarnin P. Developing a Return to Work Intervention for Breast Cancer Survivors with the Intervention Mapping Protocol: Challenges and Opportunities of the Needs Assessment. Front Public Health. 2018 Feb 23;6:35.

Pérol O, Charbotel B, Perrier L, Bonnand S, Belladame E, Avrillon V, Rebattu P, Gomez F, Lauridant G, Pérol M, Fervers B. Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort. Int J Environ Res Public Health. 2018 Jan 4;15(1).

Havet N, Penot A, Plantier M, Charbotel B, Morelle M, Fervers B. Do regulations protect workers from occupational exposures to carcinogenic, mutagenic and reprotoxic (CMR) agents in France? Occup Environ Med. 2018 May;75(5):389-397.

Coudon T, Hourani H, Nguyen C, Faure E, Mancini FR, Fervers B, Salizzoni P.Assessment of long-term exposure to airborne dioxin and cadmium concentrations in the Lyon metropolitan area (France). Environ Int. 2018 Feb;111:177-190.

Mancini FR, Rajaobelina K, Praud D, Dow C, Antignac JP, Kvaskoff M, Severi G, Bonnet F, Boutron-Ruault MC, Fagherazzi G. Nonlinear associations between dietary exposures to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS) and type 2 diabetes risk in women: Findings from the E3N cohort study. Int J Hyg Environ Health. 2018 Aug;221(7):1054-1060.

 

Praud D, Parpinel M, Guercio V, Bosetti C, Serraino D, Facchini G, Montella M, La Vecchia C, Rossi M. Proanthocyanidins and the risk of prostate cancer in Italy. Cancer Causes Control. 2018 Feb;29(2):261-268.

 

2017

Ferlazzo ML, Foray N. Space radiobiology needs realistic hypotheses and relevant methodology. Proc Natl Acad Sci USA 2017 Aug 15;114(33):E6733

Le Cornet C, Fervers B, Pukkala E, Tynes T, Feychting M, Hansen J, Togawa K, Nordby KC, Oksbjerg Dalton S, Uuksulainen S, Wiebert P, Woldbæk T, Skakkebæk NE, Olsson A, Schüz J. Parental Occupational Exposure to Organic Solvents and Testicular Germ Cell Tumors in their Offspring: NORD-TEST Study. Environ Health Perspect. 2017 Jun 30;125(6):067023.

Varin M, Charbotel B, Pérol O, Perrier L, Massardier-Pilonchéry A, Bonnand S, Belladame E, Fort E, Avrillon V, Rebattu P, Pérol M, Fervers B. [Assessment of a self-administered questionnaire identifying occupational exposures among lung cancer patients]. Bull Cancer. 2017 Jun;104(6):559-564

Havet N, Penot A, Morelle M, Perrier L, Charbotel B, Fervers B. Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003-10. Eur J Public Health. 2017 Jun 1;27(3):425-432.

Faure E, Danjou AM, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Fervers B. Accuracy of two geocoding methods for geographic information system-based exposure assessment in epidemiological studies. Environ Health. 2017 Feb 24;16(1):15

Havet N, Penot A, Morelle M, Perrier L, Charbotel B, Fervers B. Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France. Int Arch Occup Environ Health. 2017 Feb;90(2):227-241.

Clément F, Xu X, Donini CF, Clément A, Omarjee S, Delay E, Treilleux I, Fervers B, Le Romancer M, Cohen PA, Maguer-Satta V.Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling. Cell Death Differ. 2017 Jan;24(1):155-166.

Coste A, Hémon D, Orsi L, Boniol M, Doré JF, Faure L, Clavel J, Goujon S. Residential exposure to ultraviolet light and risk of precursor B-cell acute lymphoblastic leukemia: assessing the role of individual risk factors, the ESCALE and ESTELLE studies. Cancer Causes Control. 2017 Oct;28(10):1075-1083.

2016

Togawa K, Le Cornet C, Feychting M, Tynes T, Pukkala E, Hansen J, Olsson A, Oksbjerg Dalton S, Nordby KC, Uuksulainen S, Wiebert P, Woldbæk T, Skakkebæk NE, Fervers B, Schüz J. Parental Occupational Exposure to Heavy Metals and Welding Fumes and Risk of Testicular Germ Cell Tumors in Offspring: A Registry-Based Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1426-1434

2015

Le Cornet C, Fervers B, Dalton SO, Feychting M, Pukkala E, Tynes T, Hansen J, Nordby KC, Béranger R, Kauppinen T, Uuksulainen S, Wiebert P, Woldbæk T, Skakkebæk NE, Olsson A, Schüz J. Testicular germ cell tumours and parental occupational exposure to pesticides: a register-based case-control study in the Nordic countries (NORD-TEST study). Occup Environ Med. 2015 Nov;72(11):805-11.

Danjou AM, Fervers B, Boutron-Ruault MC, Philip T, Clavel-Chapelon F, Dossus L. Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort. Breast Cancer Res. 2015 Mar 17;17:39

Cettier J, Bayle ML, Béranger R, Billoir E, Nuckols JR, Combourieu B, Fervers B. Efficiency of wipe sampling on hard surfaces for pesticides and PCB residues in dust. Sci Total Environ. 2015 Feb 1;505:11-21.

Foucaut AM, Berthouze SE, Touillaud M, Morelle M, Bourne-Branchu V, Kempf-Lépine AS, Carretier J, Pérol D, Trédan O, Bachmann P, Fervers B. Deterioration of Physical Activity Level and Metabolic Risk Factors After Early-Stage Breast Cancer Diagnosis.Cancer Nurs. 2015 Jul-Aug;38(4):E1-9.

Vernez D, Koechlin A, Milon A, Boniol M, Valentini F, Chignol MC, Doré JF, Bulliard JL, Boniol M. Anatomical UV Exposure in French Outdoor Workers. J Occup Environ Med. 2015 Nov;57(11):1192-6.

Coste A, Goujon S, Boniol M, Marquant F, Faure L, Doré JF, Hémon D, Clavel J. Residential exposure to solar ultraviolet radiation and incidence of childhood hematological malignancies in France. Cancer Causes Control. 2015 Sep;26(9):1339-49.

Boniol M, Koechlin A, Boniol M, Valentini F, Chignol MC, Doré JF, Bulliard JL, Milon A, Vernez D. Occupational UV exposure in French outdoor workers. J Occup Environ Med. 2015 Mar;57(3):315-20.

Vernez D, Milon A, Vuilleumier L, Bulliard JL, Koechlin A, Boniol M, Doré JF. A general model to predict individual exposure to solar UV by using ambient irradiance data. J Expo Sci Environ Epidemiol. 2015 Jan;25(1):113-8.

2014

Pereira S, Malard V, Ravanat JL, Davin AH, Armengaud J, Foray N, Adam-Guillermin C. Low doses of gamma-irradiation induce an early bystander effect in zebrafish cells which is sufficient to radioprotect cells.PLoS One. 2014 Mar 25;9(3):e92974.

Binachon B, Dossus L, Danjou AM, Clavel-Chapelon F, Fervers B. Life in urban areas and breast cancer risk in the French E3N cohort. Eur J Epidemiol. 2014 Oct;29(10):743-51.

Béranger R, Pérol O, Bujan L, Faure E, Blain J, Le Cornet C, Flechon A, Charbotel B, Philip T, Schüz J, Fervers B. Studying the impact of early life exposures to pesticides on the risk of testicular germ cell tumors during adulthood (TESTIS project): study protocol. BMC Cancer. 2014 Aug 4;14:563.

Béranger R, Blain J, Baudinet C, Faure E, Fléchon A, Boyle H, Chasles V, Charbotel B, Schüz J, Fervers B. [Testicular germ cell tumours and early exposures to pesticides: The TESTEPERA pilot study]. Bull Cancer. 2014 Mar;101(3):225-35.

Dossus L, Boutron-Ruault MC, Kaaks R, Gram IT, Vilier A, Fervers B, Manjer J, Tjonneland A, Olsen A, Overvad K, Chang-Claude J, Boeing H, Steffen A, Trichopoulou A, Lagiou P, Sarantopoulou M, Palli D, Berrino F, Tumino R, Vineis P, Mattiello A, Bueno-de-Mesquita HB, van Duijnhoven FJ, Bakker MF, Peeters PH, Weiderpass E, Bjerkaas E, Braaten T, Menéndez V, Agudo A, Sanchez MJ, Amiano P, Tormo MJ, Barricarte A, Butt S, Khaw KT, Wareham N, Key TJ, Travis RC, Rinaldi S, McCormack V, Romieu I, Cox DG, Norat T, Riboli E, Clavel-Chapelon F. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014 Apr 15;134(8):1871-88.

Le Cornet C, Lortet-Tieulent J, Forman D, Béranger R, Flechon A, Fervers B, Schüz J, Bray F. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer. 2014 50(4):831-9.

Foucaut AM, Berthouze-Aranda SE, Touillaud M, Kempf-Lépine AS, Baudinet C, Meyrand R, Carretier J, Bachmann P, Fervers B. Reduction of health risk factors through an adapted physical activity program in patients with breast cancer. Support Care Cancer. 2014 Apr;22(4):1097-104.

Delcourt C, Cougnard-Grégoire A, Boniol M, Carrière I, Doré JF, Delyfer MN, Rougier MB, Le Goff M, Dartigues JF, Barberger-Gateau P, Korobelnik JF. Lifetime exposure to ambient ultraviolet radiation and the risk for cataract extraction and age-related macular degeneration: the Alienor Study. Invest Ophthalmol Vis Sci. 2014 Oct 21;55(11):7619-27.

Pôle d'Unité "SCIENCES HUMAINES ET SOCIALES" 

2019

Foray N, Bourguignon 'Considerations on the use of the terms radiosensitivity and radiosusceptibility' by Wojcik et al. J Radiol Prot. 2019 Mar;39(1):309-313.

2018

Britel M, Bourguignon M, Foray N The use of the term 'radiosensitivity' through history of radiation: from clarity to confusion. Int J Radiat Biol. 2018 May;94(5):503-512.

2017

*Britel M, Pérol O, Blois Da Conceiçao S, Ficty M, Brunet H, Avrillon V, Charbotel B, Fervers B. [Motivations and obstacles to occupational disease claims in lung cancer patients: an exploratory psychosocial study].Sante Publique. 2017 Oct 2;29(4):569-578.

Foray N. [Fabien Arcelin (1876-1942), or how to become a radiation oncologist when born an archeologist].Cancer Radiother. 2017 May;21(3):228-238.

Foray N, Amiel M, Mornex R. [Étienne Destot (1864-1918) or the other father of French radiology]. Cancer Radiother. 2017 Apr;21(2):138-147

2016

Foray N. [1896: How nascent radiotherapy gathered Roentgen, Pasteur and the Lumière brothers]. Cancer Radiother. 2016 Dec;20(8):820-823

2015

Britel M, Foray N, Préau M. [Personalized medicine in radiotherapy: practitioners' perception]. Sante Publique. 2015 27(5):669-77.

Foray N. [Léon Bouchacourt (1865-1949): How an obstetrician pointed out individual radiosensitivity].Cancer Radiother. 2015 Dec;19(8):752-61.

Nos Revues

Pôle d’Unité « RADIOBIOLOGIE FONDAMENTALE »

 

2020

 

Averbeck D, Candéias S, Chandna S, Foray N, Friedl AA, Haghdoost S, Jeggo PA, Lumniczky K, Paris F, Quintens R, Sabatier L. Establishing mechanisms affecting the individual response to ionizing radiation. Int J Radiat Biol. 2020 Mar;96(3):297-323.

 

2019

 

Berthel E, Ferlazzo ML, Devic C, Bourguignon M, Foray N. What Does the History of Research on the Repair of DNA Double-Strand Breaks Tell Us?-A Comprehensive Review of Human Radiosensitivity.Int J Mol Sci. 2019 Oct 26;20(21).

 

Berthel E, Foray N, Ferlazzo ML.The Nucleoshuttling of the ATM Protein: A Unified Model to Describe the Individual Response to High- and Low-Dose of Radiation? Cancers (Basel). 2019 Jun 28;11(7).

Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S. Cold Tumors: A Therapeutic Challenge for Immunotherapy. Front Immunol. 2019 Feb 8;10:168

 

2018

 

Ferlazzo ML, Devic C, Granzotto A, Charvet AM, Pilleul F, Colin C, Biston MC, Joubert A, Bourguignon M, Foray N. DNA breaks induced by iodine-containing contrast medium in radiodiagnostics: a problem of tungsten? Eur Radiol Exp. 2018 Aug 15;2:21.

Devic C, Ferlazzo ML, Foray N.Influence of Individual Radiosensitivity on the Adaptive Response Phenomenon: Toward a Mechanistic Explanation Based on the Nucleo-Shuttling of ATM Protein.Dose Response. 2018 Aug 6;16(3):1559325818789836

 

2017

 

Ferlazzo ML, Bourguignon M, Foray N. Functional Assays for Individual Radiosensitivity: A Critical Review.Semin Radiat Oncol. 2017 Oct;27(4):310-315.

Shekarian T, Valsesia-Wittmann S, Brody J, Michallet MC, Depil S, Caux C, Marabelle A. Pattern recognition receptors: immune targets to enhance cancer immunotherapy. Ann Oncol. 2017 Aug 1;28(8):1756-1766

 

2016

 

Foray N, Bourguignon M, Hamada N. Individual response to ionizing radiation. Mutat Res Rev. 2016 Oct - Dec;770(Pt B):369-386.

Ferlazzo ML, Foray N. Huntington Disease: A Disease of DNA Methylation or DNA Breaks? Am J Pathol. 2016 Jul;186(7):1750-3.

Bodgi L, Canet A, Pujo-Menjouet L, Lesne A, Victor JM, Foray N. Mathematical models of radiation action on living cells: From the target theory to the modern approaches. A historical and critical review. J Theor Biol. 2016 Apr 7;394:93-101.

Bodgi L, Canet A, Granzotto A, Britel M, Puisieux A, Bourguignon M, Foray N. The enigma of the biological interpretation of the linear-quadratic model finally resolved? A summary for non-mathematicians]. Cancer Radiother. 2016 Jun;20(4):314-21

 

Viau M, Perez AF, Bodgi L, Devic C, Granzotto A, Ferlazzo ML, Bourguignon M, Puisieux A, Lacornerie T, Lartigau É, Lagrange JL, Foray N.[Repeated radiation dose effect and DNA repair: Importance of the individual factor and the time interval between the doses]. Cancer Radiother. 2016 May;20(3):217-25

 

Pauwels EK, Foray N, Bourguignon MH. Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose Radiobiology. Med Princ Pract. 2016;25(2):101-9.

Poulard C, Corbo L, Le Romancer M. Protein arginine methylation/demethylation and cancer. Oncotarget. 2016 Oct 11;7(41):67532-67550.

 

Masuzzo A, Dinet V, Cavanagh C, Mascarelli F, Krantic S. Amyloidosis in Retinal Neurodegenerative Diseases. Front Neurol. 2016 Aug 8;7:127.

 

2015

 

Perez AF, Devic C, Colin C, Foray N. [The low doses of radiation: Towards a new reading of the risk assessment]. Bull Cancer. 2015 Jun;102(6):527-38.

Lesne A, Foray N, Cathala G, Forné T, Wong H, Victor JM. Chromatin fiber allostery and the epigenetic code.J Phys Condens Matter. 2015 Feb 18;27(6):064114

Vilquin P, Cohen P, Maudelonde T, Tredan O, Treilleux I, Bachelot T, Heudel PE. [New therapeutical strategies in metastatic hormone-dependent breast cancer]. Bull Cancer. 2015 Apr;102(4):367-80.

Shekarian T, Valsesia-Wittmann S, Caux C, Marabelle A. Paradigm shift in oncology: targeting the immune system rather than cancer cells. Mutagenesis. 2015 Mar;30(2):205-11.

 

2014

 

Lavelle C, Foray N. Chromatin structure and radiation-induced DNA damage: from structural biology to radiobiology. Int J Biochem Cell Biol. 2014 Apr;49:84-97.

 

Fujiwara H, Yokota H, Monk B, Treilleux I, Devouassoux-Shisheboran M, Davis A, Kim JW, Mahner S, Stany M, Pignata S, Ray-Coquard I, Fujiwara K. Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S96-101

 

Pôle d’Unité “DEFENSE”

 

2014

 

Drouet M, Hérodin F. Mitigating radiation-induced toxicity: an overview of new approaches developed at the French Military Biomedical Research Institute. Health Phys. 2014 Jun;106(6):682-8.

 

Pôle d’Unité “SANTE”

 

2019

 

Jagadeeshan S, Prasad M, Ortiz-Cuaran S, Gregoire V, Saintigny P, Elkabets M. Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations. Trends Cancer. 2019 Jun;5(6):365-390

 

Gardin I, Grégoire V, Gibon D, Kirisli H, Pasquier D, Thariat J, Vera P. Radiomics: Principles and radiotherapy applications. Crit Rev Oncol Hematol. 2019 Jun;138:44-50.

 

2018

 

Simon C, Caballero C, Gregoire V, Thurnher D, Koivunen P, Ceruse P, Spriano G, Nicolai P, Licitra L, Machiels JP, Hamoir M, Andry G, Mehanna H, Hunter KD, Dietz A, René Leemans C. Eur Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study. J Cancer. 2018 ;103:69-77.

 

Grégoire V, Thorwarth D, Lee JA. Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises? Semin Radiat Oncol. 2018 Jan;28(1):35-45.

 

Frappaz D, Faure-Conter C, Bonneville Levard A, Barritault M, Meyronet D, Sunyach MP. Medulloblastomas in adolescents and adults - Can the pediatric experience be extrapolated? Neurochirurgie. 2018 Dec 13. S0028-3770(18)30361-8.

Frappaz D, Faure-Conter C, Meyronet D, Levard-Bonneville A, Beuriat PA, Sunyach MP, Barritault M. Are molecular subgroups of medulloblastomas really prognostic? Curr Opin Neurol. 2018 Dec;31(6):747-751.

Legouté F, Padovani L, Claude L, Bolle S, Attal J, Gonzalez-Moya A, Lizée T, Paumier A, Jadaud É, Pointreau Y, Dufreneix S, Laprie A. [Interest of image-guided radiotherapy for brain tumors and positioning control].Cancer Radiother. 2018 Oct;22(6-7):593-601.

Dourthe ME, Bolle S, Temam S, Jouin A, Claude L, Reguerre Y, Defachelles AS, Orbach D, Fresneau B. Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future. J Pediatr Hematol Oncol. 2018 Mar;40(2):85-92.

Mastier C, Gjorgjievska A, Thivolet A, Bouhamama A, Cuinet M, Pilleul F, Tselikas L, de Baère T, Deschamps F Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox. Semin Intervent Radiol. 2018 Oct;35(4):281-289.

Bachelet JT, Berhouma M, Shipkov H, Kodjikian L, Jouanneau E, Gleizal A Orbital Cavernous Hemangioma Causing Spontaneous Compressive Hemorrhage. J Craniofac Surg. 2018 May;29(3):706-708.

 

2017

 

Giraudet AL, Taïeb D. PET imaging for thyroid cancers: Current status and future directions. Ann Endocrinol. 2017;78(1):38-42.

 

2016

 

Henriques de Figueiredo B, Grégoire V. How to minimize morbidity in radiotherapy of pharyngolaryngeal tumors? Curr Opin Otolaryngol Head Neck Surg. 2016 Apr;24(2):163-9

 

Pommier P, Guérif S, Peiffert D, Créhange G, Hannoun-Lévi JM, de Crevoisier R. [Prostate cancer brachytherapy]. Cancer Radiother. 2016 Sep;20 Suppl:S210-5

De Crevoisier R, Pommier P, Latorzeff I, Chapet O, Chauvet B, Hennequin C. [Prostate cancer external beam radiotherapy]. Cancer Radiother. 2016 Sep;20 Suppl:S200-9

Espenel S, Vallard A, Langrand-Escure J, Ben Mrad M, Méry B, Rivoirard R, Moriceau G, Guy JB, Trone JC, Moncharmont C, Wang G, Diao P, Bernichon É, Chanal É, Fournel P, Magné N. [Carcinomatous meningitis: The radiation therapist's point of view]. Cancer Radiother. 2016 Feb;20(1):54-9.

Moureau-Zabotto L, Delannes M, Le Péchoux C, Sunyach MP, Kantor G, Sargos P, Thariat J, Llacer-Moscardo C. [Management of soft tissues sarcoma of the limbs by external beam radiation therapy]. Cancer Radiother. 2016 Apr;20(2):133-40.

Claude L, Morelle M, Mancini S, Duncan A, Sebban H, Carrie C, Marec-Berard P. [Use of hypnosis in radiotherapy as an alternative to general anesthesia in pediatric radiation oncology]. Bull Cancer. 2016 Nov;103(11):921-927.

Laprie A, Padovani L, Bernier V, Supiot S, Huchet A, Ducassou A, Claude L.[Radiotherapy for paediatric cancers]. Cancer Radiother. 2016 Sep;20 Suppl:S216-26.

Kortmann RD, Freeman C, Marcus K, Claude L, Dieckmann K, Halperin E, Esiashvili N, Paulino A, Mahajan A, Seiersen K, Ahern V, Ricardi U, Carrie C. Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS). Radiother Oncol. 2016 May;119(2):357-60.

Guimas V, Thariat J, Graff-Cailleau P, Boisselier P, Pointreau Y, Pommier P, Montbarbon X, Laude C, Racadot S. [Intensity modulated radiotherapy for head and neck cancer, dose constraint for normal tissue: Cochlea vestibular apparatus and brainstem]. Cancer Radiother. 2016 Oct;20(6-7):475-83.

Thariat J, Racadot S, Pointreau Y, Boisselier P, Grange JD, Graff P, Weber DC. [Intensity-modulated radiotherapy of head and neck cancers: Dose effects on the ocular, orbital and eyelid structures]. Cancer Radiother. 2016 Oct;20(6-7):467-74.

Graff P, Woisard V, Racadot S, Thariat J, Pointreau Y.[Head and neck intensity-modulated radiation therapy: Normal tissues dose constraints. Pharyngeal constrictor muscles and larynx]. Cancer Radiother. 2016 Oct;20(6-7):452-8.

Lapeyre M, Biau J, Racadot S, Moreira JF, Berger L, Peiffert D. [Radiotherapy for oral cavity cancers]. Cancer Radiother. 2016 Sep;20 Suppl:S116-25.

Bachelet JT, Shipkov H, Breton P, Berhouma M, Jouanneau E, Gleizal A. [Surgical approaches of tumors of the posterior cone of the orbit]. Rev Stomatol Chir Maxillofac Chir Orale. 2016 Apr;117(2):89-95

 

2015

 

Grégoire V, Langendijk JA, Nuyts S. Advances in Radiotherapy for Head and Neck Cancer. J Clin Oncol. 2015 Oct 10;33(29):3277-84.

 

Konert T, Vogel W, MacManus MP, Nestle U, Belderbos J, Grégoire V, Thorwarth D, Fidarova E, Paez D, Chiti A, Hanna GG. PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. Radiother Oncol. 2015 Jul;116(1):27-34.

 

Differding S, Hanin FX, Grégoire V. PET imaging biomarkers in head and neck cancer. Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):613-22.

 

Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU). Cancer Treat Rev. 2015 Dec;41(10):814-20.

Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, Ladenstein R, Michon J, Hjorth L, Judson I, Luksch R, Bernstein ML, Marec-Bérard P, Brennan B, Craft AW, Womer RB, Juergens H, Oberlin O. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. J Clin Oncol. 2015 Sep 20;33(27):3036-46.

Claude L, Faure-Conter C, Frappaz D, Mottolèse C, Carrie C. Radiation therapy in pediatric pineal tumors.Neurochirurgie. 2015 Apr-Jun;61(2-3):212-5

Mann RM, Balleyguier C, Baltzer PA, Bick U, Colin C, Cornford E, Evans A, Fallenberg E, Forrai G, Fuchsjäger MH, Gilbert FJ, Helbich TH, Heywang-Köbrunner SH, Camps-Herrero J, Kuhl CK, Martincich L, Pediconi F, Panizza P, Pina LJ, Pijnappel RM, Pinker-Domenig K, Skaane P, Sardanelli F; European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition. Breast MRI: EUSOBI recommendations for women's information. Eur Radiol. 2015 Dec;25(12):3669-78.

 

Perez AF, Devic C, Colin C, Foray N. [The low doses of radiation: Towards a new reading of the risk assessment]. Bull Cancer. 2015 Jun;102(6):527-38.

Bachelet JT, Combemale P, Devic C, Foray N, Jouanneau E, Breton P. [Management of craniofacial type 1 neurofibromatosis]. Rev Stomatol Chir Maxillofac Chir Orale. 2015 Sep;116(4):209-14.

 

2014

 

Hamoir M, Schmitz S, Gregoire V. The role of neck dissection in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. 2014 Dec;15(4):611-24.

 

Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, Hamoir M Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep. 2014 Jun 2;6:44.

 

Hamoir M, Troussier I, Machiels JP, Reychler H, Schmitz S, Thariat J, Grégoire V. [Lymph node metastases from squamous cell carcinoma of unknown primary site. Is it time to change of paradigm?]. Bull Cancer. 2014 May 1;101(5):455-60.

 

Bol V, Grégoire V. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers. Biomed Res Int. 2014;2014:696028

 

Paleri V, Roe JW, Strojan P, Corry J, Grégoire V, Hamoir M, Eisbruch A, Mendenhall WM, Silver CE, Rinaldo A, Takes RP, Ferlito A. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck. 2014 Mar;36(3):431-43.

 

De Crevoisier R, Castelli J, Guérif S, Pommier P, Créhange G, Chauvet B, Lagrange JL. [Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues]. Cancer Radiother. 2014 Oct;18(5-6):369-78.

Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, Bossi A, Le Prisé E, Guerif S, Simon JM, Dubray B, Zhu J, Lagrange JL, Pommier P, Gnep K, Acosta O, De Crevoisier R. Nomograms to predict late urinary toxicity after prostate cancer radiotherapy. World J Urol. 2014 Jun;32(3):743-51

Falk AT, Moncharmont C, Guilbert M, Guy JB, Alphonse G, Trone JC, Rivoirard R, Gilormini M, Toillon RA, Rodriguez-Lafrasse C, Magné N. [Radiation-induces increased tumor cell aggressiveness of tumors of the glioblastomas?]. Bull Cancer. 2014 Sep;101(9):876-80.

Guy JB, Trone JC, Casteillo F, Forest F, Pacaut C, Moncharmont C, Espenel S, Vallard A, Langrand Escure J, Collard O, Peoc'h M, Magné N. [Carcinosarcomas in female genital tracts: general review]. Bull Cancer. 2014 Jul-Aug;101(7-8):760-4.

Moncharmont C, Levy A, Guy JB, Falk AT, Guilbert M, Trone JC, Alphonse G, Gilormini M, Ardail D, Toillon RA, Rodriguez-Lafrasse C, Magné N. Radiation-enhanced cell migration/invasion process: a review. Crit Rev Oncol Hematol. 2014 Nov;92(2):133-42.

Trone JC, Guy JB, Mery B, Langrand Escure J, Lahmar R, Moncharmont C, Rivoirard R, Semay T, Chauleur C, Collard O, Vignot S, Magné N. [Melanomas of the female genital tract: state of the art]. Bull Cancer. 2014 Jan 1;101(1):102-6.

Ayadi M, Zahra N, Thariat J, Bouilhol G, Boissard P, Van Houtte P, Claude L, Mornex F.[Intensity-modulated radiation therapy in non-small cell lung cancers]. Cancer Radiother. 2014 Oct;18(5-6):406-13.

Bachelet JT, Mojallal A, Boucher F. [Female genital surgery, G-spot amplification techniques--state of the science]. Ann Chir Plast Esthet. 2014 Oct;59(5):344-7.

Colin C, Schott AM, Valette PJ. Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening. Eur Radiol. 2014 Oct;24(10):2412-6.

Sassolas B, Mourrégot A, Thariat J, Tiffet O, Dygai-Cochet I, Mirabel X, Truc G, Cupissol D, Modiano P, Combemale P, Bedane C, Derrey S, Lamant L, Lubrano V, Siegrist S, Rougé-Bugat MÈ, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT. [Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines]. Bull Cancer. 2014 Jan 1;101(1):9-16.

 

Pôle d’Unité « ENVIRONNEMENT ET ESPACE »

 

2019

 

Gandini S, Doré JF, Autier P, Greinert R, Boniol M. Epidemiological evidence of carcinogenicity of sunbed use and of efficacy of preventive measures. J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:57-62.

 

2017

 

Doré JF, Chignol MC. UV Driven Tanning Salons: Danger on Main Street. Adv Exp Med Biol. 2017;996:335-346.

 

2016

 

Carretier J, Boyle H, Duval S, Philip T, Laurence V, Stark DP, Berger C, Marec-Bérard P, Fervers B. A Review of Health Behaviors in Childhood and Adolescent Cancer Survivors: Toward Prevention of Second Primary Cancer. J Adolesc Young Adult Oncol. 2016 Jun;5(2):78-90.

 

2015

 

Duval S, Carretier J, Boyle H, Philip T, Berger C, Marec-Bérard P, Fervers B. [Life style and occupational factors and prevention of second primary cancers after childhood and adolescent cancer: Current state of knowledge]. Bull Cancer. 2015 ;102(7-8):665-73.

 

2014

 

Charbotel B, Fervers B, Droz JP. Occupational exposures in rare cancers: A critical review of the literature.Crit Rev Oncol Hematol. 2014 May;90(2):99-134

Bounin A, Charbotel B, Fervers B, Bergeret A. [Professional risk factors associated with the cancer of the ovary. Literature review].Bull Cancer. 2014 Dec;101(12):1089-108.

Livres et Chapitres de livres

Pôle d'Unité « RADIOBIOLOGIE FONDAMENTALE »

L. Bodgi et N. Foray Effets biologiques des radiations ionisantes. Une théorie basée sur le transit cyto-nucléaire de la protéine ATM. Applications à la radiothérapie. (2016) Editions Universitaires Européennes, Sarrebruck, Germany – ISBN :978-3-639-47486-2

 

Pôle d'Unité « ENVIRONNEMENT ET ESPACE »

Perrez M, Fervers B, Cancer : Quels risques ?, Editions Quae, 2018

Pôle d'Unité « SCIENCES HUMAINES ET SOCIALES»

Préau, M. and Siméone, A. De l’expertise scientifique à l’expertise profane. Paris, Éditions des Archives Contemporaines. 2018

 

CHAPITRES

 

Pôle d'Unité « RADIOBIOLOGIE FONDAMENTALE »

Ferlazzo ML and Foray N Chapitre The Huntington’s disease protein participates to the nucleo-shuttling of the ATM kinase In: HUNTINGTON’S DISEASE Prevalence, Pathogenesis and treatment. Ed Christina Hughes Nova Science Publishers, 2016.

Pôle d'Unité « DEFENSE »

Dorandeu F, Labadie P, Drouet M, Renard C, Calami F. Prise en charge de victimes d’un attentat terroriste non conventionnel NRBC. Le blessé par attentat terrorriste. Arnette Editor ; John Libbey Eurotext 2017.

Pôle d'Unité « SANTE »

M. Baumann, M. Krause, V. Grégoire, Modified fractionation. In Michael C. Joiner and Albert J. van der Kogel, eds., Basic Clinical Radiobiology, 5thedition, CRC Press, 125-135, 2018.

M.Bourguignon. Potential impact of radiation biology and radiation protection in nuclear medicine and corresponding regulatory issues. In Therapeutic Nuclear Medicine. R.Baum Editor. Springer, 835-842, 2014

V. Grégoire, JP Machiels, M. Baumann, Combined radiotherapy and chemotherapy. In Michael C. Joiner and Albert J. van der Kogel, eds., Basic Clinical Radiobiology, 5th edition, CRC Press, 217-240, 2018.